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Abstract 
VENOMIC CHARACTERIZATION OF THE TEREBRIDAE AND NOVEL TEREBRID 
NEUROPEPTIDES 
By 
Mary Elizabeth Wright 
Adviser:  Dr. Mande Holford 
Unravelling the complex mixture of neuropeptides produced by the terebrid venom duct holds the promise 
of discovering tomorrow’s therapeutics.  Cone snails have already demonstrated the potential found in the 
venom of these unusual marine organisms, through the commercial approval of drugs for pain and other 
indications.  Terebrids, as the sister family to the cone snails, have been much less investigated, but have 
a species richness that makes them very attractive in the search for novel neuropeptides.  The venomics 
research described in this work encompasses the first comprehensive characterization of the terebrid 
venom duct transcriptomes of two species, Cinguloterebra anilis and Terebra subulata.  De novo 
assembly and analysis were performed using next generation sequencing technology and state of the art 
bioinformatics tools to identify the cocktail of peptides, teretoxins, produced by the venom duct.  These 
disulfide rich peptides often show a remarkable specificity for subtypes of ion channels and ligand-gated 
receptors, giving them therapeutic potential, but they are only available in vanishingly small amounts from 
the natural source.  As a result, identification of teretoxins using next generation sequencing is a prelude 
to synthesizing them in sufficient quantities to test for bioactivity.  Here recombinant expression and solid 
phase peptide synthesis have both been utilized for the synthesis of four different teretoxins, with a 
special focus on recombinant synthesis to design a reproducible strategy for synthesizing disulfide rich 
peptides greater than 40 amino acids in length.  Preliminary characterization of bioactivity was performed 
by injecting synthesized toxin into the polychaete N. virens.  A teretoxin identified from Terebra guttata, 
Tg77, has produced promising results in this assay, with repeated trials showing the effects of 
uncoordinated movement and rigid paralysis.  Further testing on Tg77 and other teretoxins will be carried 
forward, with an evident need for high throughput assays to provide an efficient means for the testing of 
novel compounds with a variety of potential molecular targets. 
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Chapter 1 
Introduction 
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1.1. Peptide drug development from venomous organisms 
As the pharmaceutical pipeline diminishes alternatives to small molecule drugs have garnered 
increased attention, and peptide therapeutics have seen a remarkable expansion, resulting in six new 
approvals for commercial use in 2012.1 Natural products development of bioactive neuropeptides from 
venomous marine organisms is a major resource for therapeutic applications. The bioactive venom 
peptides of marine snails are fast acting, efficient, and highly specific – all essential virtues for a 
successful drug candidate. Venomous marine snails of the superfamily Conoidea are classified into three 
major groups that include cone snails (Conidae), terebrids (Terebridae) and turrids (Turridae, which have 
recently undergone a reclassification that describes 13 monophyletic families(Fig. 1).2,3  While conoidean 
snails express peptide neurotoxins in their venom for both predation and defense, it has been discovered 
that these peptides are highly effective neuronal tools for manipulating cellular physiologies.4–6  
 
Figure 1. Representatives of the Conoidean superfamily.  These predatory marine snails are 
classified into the families Conidae (cone snails), Terebridae, and “Turridae” which has recently 
undergone reclassification into 13 monophyletic families. A. Conus marmoreus (Conidae) B. Strioterebra 
plumbea (Terebridae) C. Raphitoma sp. (Raphitomidae) (Images courtesy of Museum national d’histoire 
naturelle). 
 
The diversity of snail neuropeptide molecular targets include sodium (Na+), potassium (K+), and 
calcium (Ca2+) channels, noradrenaline transporters, and nicotinic acetylcholine (nACh) receptors, 
ensuring a significant impact on a broad range of biomedical problems related to neuronal function.7 An 
example of the potential of snail neuropeptides is Ziconotide (MVIIA), discovered in 1980’s from the 
venomous marine snail Conus magus. MVIIA, a 25 amino acid peptide, is commercially marketed as 
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Prialt® and used to alleviate chronic pain in HIV and cancer patients by inhibiting N-type calcium 
channels.8 Prior to MVIIA most pharmaceutical companies developed analgesic treatments by focusing on 
morphine like compounds that targeted opioid receptors. Morphine and other opioid receptor acting 
compounds have major side effects such as addiction and decreased potency over time. As MVIIA does 
not target opioid receptors, it does not have the same side effects as opiates. MVIIA was innovative in 
that it was the first drug developed from a marine snail, and it certified a new strategy for identifying 
analgesic compounds, namely, inhibitors of N-type calcium channels.  
Similar to MVIIA several other peptides from venomous marine organisms are currently being 
investigated for therapeutic use.9 Specifically, tumor cell proliferation may be mediated by cone snail 
peptide k-PVIIA, which binds to hERG, a potassium (K+) ion channel protein that increases in 
concentration on the cell surface of cancer cells.10 Blocking of HERG inhibits tumor cell proliferation. 
Bioactive peptides from venomous snails are a proven source for identifying new therapeutics, however 
less than 2% of identified peptide toxins from venomous snails have been characterized to the functional 
level and great numbers of venomous species remain undescribed.  
This dissertation enhances the knowledge of venomous peptides produced from predatory snails 
of the Terebridae family, an understudied group of the Conoidean superfamily, by investigating the 
diversity of terebrid venom peptides, teretoxins, and attempts to characterize the function of selected 
peptides. 
1.2. Conoidean species and venom diversity   
The globally distributed Conoidea are one of the most diverse group of venomous organisms in 
the marine realm. Cone snails are estimated to have somewhere between 500 and 800 species, while 
terebrids have approximately 300-400 species, and turrids are a paraphyletic group with as many as 
10,000 species.3,11,12 Conoidean snails vary dramatically in size. In general, cone snails are by far the 
largest, and hence the easiest to collect, while the “micro” turrids are often quite small (< 10 mm) and 
reside in deep water. The Conoidea have been perfecting the art of the hunt for the past 50 million 
years.13 Conoideans use a sophisticated venom apparatus to inject a cocktail of neuropeptides that 
rapidly immobilize their prey of sea worms, mollusks or fish. The conoidean venom apparatus includes a 
 muscular venom bulb, a slender, looping venom duct and a cleverly designed radular tooth that is 
employed as both a hypodermic need
(Figure 2).5,6  
 
 
 Cone snails and their venoms have been of great interest to the research community for at least 
three decades, given the potential of their neuropeptides as leads for drug de
systems, and yet they only represent a fraction of the species richness found in the larger Conoidean 
superfamily.  It would be fair to say that cone snails are currently the rock stars of the venomous marine 
snail world, but there are plenty of other contenders waiting for their turn in the 
snails, terebrids and turrids have enjoyed substantial evolutionary and pharmacological success as 
marine predators, and thrive in marine habitats around the world.
Conoidean snails as a group may represent a reservoir of 500,000
neuropeptides with novel functions.12
A. 
B. 
Figure 2. Conoidean venom apparatus.
muscular venom bulb, the venom gland for toxin production, a radular sac containing harpoon like 
radular teeth, and a proboscis structure from which venom laden radular tooth is injected into prey 
(Norton and Olivera, 2006) B. Electron micrograph of sample conoidean radular tooth
4 
le to inject venom into the prey and a tether to grasp the 
velopment in mammalian 
spotlight. As with cone 
12,14
  Given their species richness, 
-1,000,000 toxins for the discovery of 
  
 A. Components of conoidean venom apparatus include a 
animal 
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 Predatory snails, such as conoideans, may express up to 200 neuropeptides in their venom duct. 
The neuropeptides expressed are primarily short disulfide-rich peptides that incapacitate the prey by 
functioning primarily as agonists on array of nervous system molecular targets in a concerted manner.15 
Cone snails have often been compared to combinatorial chemists for their ability to produce libraries of 
tightly scaffolded neuropeptides arising from disulfide bonds, along with highly variable amino acid 
composition. The combination of distinct structural folds and the spatial distribution of variable residues 
enables finely calibrated subtype selectivity for a wide array of ion channels and ligand gated receptors. 
 The potency and diversity of Conus neuropeptides, referred to as conotoxins or conopeptides, 
has led to research focused on three major fronts: 1. Understanding the evolutionary forces that have 
shaped such extensive diversity; 2. Utilizing neuropeptides with high specificity for molecular targets to 
probe nervous system structure and function; and 3. Investigating a multitude of peptidic compounds as 
leads for drug discovery.16–21 The vast array of conopeptides made available by nature, driven both by the 
number of species and the complex assortment of neuropeptides found in the venom of individual 
species, provide a natural product platform for the discovery of therapeutics to treat nervous system 
disorders, such as pain, epilepsy and Parkinson’s disease, ensuring that they will continue to be 
extensively investigated.   
Where do terebrids fit in among a host of venom producing organisms that are the subject of 
ongoing research and investigation?  First and foremost, terebrids are of interest as they are a sister 
group to cone snails, however their species and venom diversity are relatively understudied. Similar to 
cone snails, terebrids express a diverse array of hypervariable disulfide-rich peptide toxins, teretoxins, 
that come in an assortment of molecular scaffolds.12,22,23 Preliminary research indicates that teretoxins, 
while similar to conotoxins, have significant differences, suggesting that investigation of terebrid venom 
has the potential to expand the horizons of marine natural product drug development. 
1.3. A brief history of conopeptide research 
While the potentially rich pharmacological resources of terebrid peptide toxins have just begun to 
be explored, it is instructive to examine the history and trajectory of cone snail research as a paradigm for 
teretoxin research. The groundbreaking nature of conotoxin research provides many lessons for the 
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discovery of natural products that modulate nervous system function, and much of what has been 
accomplished in this field provides a road map for pursuing the investigation of teretoxins, while keeping 
in mind that the pace of innovation for both genetic and proteomic research techniques is substantially 
altering the ways in which marine snail venom can be assessed, characterized and analyzed.   
 Research groups led by Baldomero Olivera, Paul Alewood, and Richard Lewis have largely 
shaped the existing knowledge of conopeptide research.24–27 Olivera and Terlau were the first to 
hypothesize that cone snails use an assortment of toxins acting in concert on different nervous system 
targets in a manner referred to as ‘cabals.’15  Specifically, the ‘lightning strike cabal’ enables rapid 
immobilization of prey through the injection of toxins that simultaneously slow Na+ channel inactivation 
and inhibit K+ channels, leading to massive depolarization across nerve cell membranes and consequent 
hyperexcitation that quickly results in a paralytic state. In contrast, the ‘nirvana cabal’, better suited to the 
hunting strategy and anatomy of Conus geographus, is composed of peptide toxins that act in concert to 
deaden the neuronal circuitry and work more slowly to produce a soporific response in the prey. 
One notable case of conopeptide discovery from the Olivera laboratory involves work from 
several talented undergraduates exploring potential conopeptide bioactivity via intracranial injection into 
mice. Their preliminary injections led to further investigation of the molecular functions of “sleeper” and 
“shaker” behavioral phenotypes elicited from specific peptide fractions.28 In the case of the “shaker” 
peptides, culled from the venom of Conus magus and Conus geographus, collaborative research 
demonstrated that N-type calcium channel currents were being potently and selectively inhibited at the 
Figure 3. Structures of representative O superfamily conotoxins targeting calcium and potassium 
channels. . Examples of well characterized conotoxins with VI/VII framework.  ω-MVIIA and ω-GVIA 
were discovered in the lab of Baldomero Olivera (Image courtesy of B. Olivera).  
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neuromuscular junction29–31.  Ultimately two of the “shaker” peptides became known as GVIA and MVIIA 
(Fig. 3), the former widely used  
to study the inhibition of synaptic transmission and disruption of N-type Ca2+ currents, while the latter was 
developed into the previously mentioned Ziconotide (Prialt ®) for the treatment of severe and chronic 
pain.8 The discovery of conotoxins GVIA and MVIIA, as well several other conotoxins of therapeutic 
interest, laid the groundwork for a major expansion of interest in cone snail research. Numerous other 
labs, including ours, have taken up the challenge of collecting venom and/or its genetic material, 
identifying the components found therein, sequencing and synthesizing peptides of interest and testing 
these for biological function. 
 Conopeptides that modulate Ca2+ channel function have been of great interest both for their 
clinical importance and ability to characterize ion channel function. There have been more than 2000 
research papers that have used GVIA as a tool for probing molecular features of the nervous system, and 
the search for antinociceptive agents has led to the characterization of conopeptides with a variety of 
other targets including Na+ channels, K+ channels, nAChRs, neurotensin receptors, N-methyl-D-
aspartate (NMDA) receptors, norepinephrine transporters and G-protein coupled receptors.32  Their broad 
repertoire of nervous system targets has resulted in clinical trials of several conopeptides as treatments 
neurophathic pain, anti-convulsants, anti-cancer, and cardioprotective agents.6,33,34 
 In spite of the impressive strides that have been made in identifying conotoxins with therapeutic 
potential, it is estimated that ~ 99% of conotoxins have yet to be characterized.35 If the majority of 
conoidean species can express up to 200 conopeptides in their venom and there are over 10,000 
conoidean species, the ~5400 protein and ~2400 nucleotide sequences derived from proteomic and 
genetic analyses currently listed on Conoserver repository website, is a painfully small fraction of 
conopeptides characterized.36 Advances in proteomics (mass spectrometry), genetic analysis (next 
generation sequencing), and high throughput bioactivity screening of identified peptide toxins promise to 
accelerate the discovery process, but it is still remarkable to contemplate the vast landscape yet to be 
explored. 
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1.4. Structural and genetic features of conoidean peptides 
 Prior to investigating the potential therapeutic effects of conoidean peptides, it is essential to first 
elucidate the structural and genetic features of these peptides to gain insight into how they function in the 
context of complex nervous systems, and to provide an overall organizational scheme for classification 
into gene superfamilies and pharmacological groupings. Conoidean peptide toxins are single gene 
products defined by highly conserved pre region at the N-terminal, which serves as a signal sequence, 
and a more variable intervening pro region, followed by a sequence with a conserved cysteine framework 
and hyper-variable amino acid content that is the mature peptide toxin (Fig. 4)15 Mature peptide toxins, 
which are cleaved by proteolysis from the precursor structure to become bioactive moieties, typically 
range between 12 and 60 amino acids in length, the shorter versions usually being conopeptides, and the 
larger versions found in terebrid and turrid peptide toxins. 
 
Figure 4. Precursor organization of conoidean peptide toxins. Includes conserved signal sequence, 
moderately variable propeptide region and as short, hypervariable mature toxin with conserved cysteine 
framework.  Representative conotoxin sequences shown for illustrative purposes (Halai and Craik, 2008).  
. The conserved precursor structure, which is the signal sequence in association with mature 
peptide cysteine frameworks, forms the basis of conoidean gene superfamilies. These superfamilies, 
designated by a capital letter, are associated with pharmacological families, designated by a greek letter 
and indicate the potential molecular channel or receptor target (Fig. 5).15,27 
 Over time, the number of gene superfamilies has grown significantly, and as a result there has 
been increasing overlap of both the cysteine frameworks and pharmacological families distributed among 
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them.37 As an illustration of these increasingly complex relationships, the M gene superfamily is now 
associated with five different cysteine frameworks (II, III, VI/VII, and XVI) and four pharmacological 
families, two of which are known, Na+ and K+ channels. Many of the recently identified gene 
superfamilies have very few representatives, and no known molecular target. In contrast, conoidean 
peptides of the well characterized A and O superfamily conotoxins have many representatives and have 
been widely researched for their inhibitory activity on nAChRs and Ca2+ among other targets. 
  
Figure 5. Gene superfamilies of disulfide-rich conopeptides. A lettered scheme shows classification 
of conopeptides gene superfamilies based on conserved signal sequence and cysteine patterns.  Gene 
superfamilies are associated with the targeting of specific types of ion channels and receptors (Akondi, et 
al, 2014). 
Conoidean disulfide connectivity varies depending on the number of cysteines (Cys) and their 
distribution in the mature peptide toxin27. One common and well known bonding pattern is the cysteine 
knot referred to as the ICK (Inhibitor Cysteine Knot) motif. ICK motif which arises from a 6 Cys framework 
in which three disulfides form a loop that is threaded by the third disulfide bond (Fig. 3). The ICK motif is 
common among conoidean and arachnid neuropeptides. One of the most familiar ICK motif peptides are 
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Huwentoxins (HWTX) from Chinese bird spider Haplopelma huwena.38,39 Recently, ICK motif peptides 
were found in the venom of the Australian scorpion, Liocheles waigiensis.40 The discovery of the ICK 
structure in scorpion supports the hypothesis of functionally divergent and convergent evolution of the 
ICK scaffold across evolutionary time and taxa. ICK motif peptides are largely antagonists and are active 
on a large variety of molecular targets.41 
 An unusual feature of conotoxins is the extent to which they exhibit post-translational 
modifications, which confer chemical and structural changes to individual amino acids.42,43 A few 
examples of these modifications include hydroxylation of proline, gamma carboxylation of glutamate and 
bromination of tryptophan. While most if not all of the PTMs found in cone snails are found in mammalian 
and other systems, the density of these changes to the relatively short conotoxins sets them apart. From 
what has been observed thus far, at least 15 different modification enzymes are involved in conferring 
these alterations. The role of PTMs in bioactivity is not always clear. In some cases they are essential for 
bioactivity although this is not always the case. It is proposed that PTMs play a role in enhancing the 
diversity of conotoxin biophysical properties so that they may have greater selectivity for molecular targets 
in the nervous system.43  
1.5. Structural and genetic features of teretoxins  
 In comparison to conotoxins, less is known about teretoxin structural features and genetic 
organization. However, preliminary research has begun to identify the similarities and significant 
differences in terms of overall structural features (Table 1). To date the majority of the work characterizing 
teretoxins has been on the genetic level, where it has been established that a similar precursor structure 
of conserved signal sequence, intervening pro region, and highly variable mature toxin with conserved 
cysteine framework is present, although the propeptide region is less likely to be observed44,45. A 
propeptide region is not always present in conotoxins, but this seems to be a more common feature in 
teretoxins. As with conotoxins, the mature toxin is released from the precursor structure via proteolytic 
processing and prior to assuming bioactivity. 
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Table 1. Comparison of structural and genetic features of conotoxins and teretoxins 
Structural Features Cone Snails Terebrids 
Pre-Pro Organization ✔ ✔ 
Mature peptide length Average 10 – 30   Often >40 
Conserved cysteine pattern ✔ ✔ 
Highly variable amino acids ✔ ✔ 
Post translational modification ✔ ? 
 
 Teretoxins, in general, are longer than their conotoxin counterparts. Teretoxins are often 40 
amino acids or longer in length, whereas conotoxins average closer to 30 amino acids in length.  Many of 
the conserved cysteine frameworks discovered thus far in teretoxins exhibit the same pattern found in 
conotoxins, which means that the number of intervening amino acids between cysteine residues is 
greater than conotoxins. The length of teretoxins is comparable to the neuropeptides of other venomous 
organisms, such as spiders and scorpions, where cysteine rich peptides targeting ion channels and 
ligand-gated receptors are often >40 amino acids.46 The increased length of teretoxins also results from a 
tendency towards conserved frameworks that have eight Cys, which is not as common in cone snails, 
and a paucity of the four Cys frameworks that are quite plentiful in cone snails. 
 Too few teretoxins have been characterized thus far to accomplish the work of classifying their 
toxins into gene superfamilies, or to evaluate whether similar relationships exist between conserved 
signal sequences and cysteine frameworks. It is also not known how precursor structures of conserved 
signal sequence in association with Cys framework may relate to pharmacological function.  Thus far, the 
teretoxin signal sequences identified show little homology with conotoxin signal sequences, perhaps 
signifying the substantial evolutionary distance between these sister families.  
 Currently it is an open question as to the degree of post-translational modifications carried by 
teretoxins, although preliminary evidence has suggested either a lack or a very low level of the types 
found in conotoxins.45,47 This is a surprising finding given that conotoxins are some of the most highly 
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post-translationally modified peptides known, with a wide array of modifications.  It has also been 
demonstrated that post-translational modifications exist in some species of turrids.48 As the proteomic 
research performed thus far to identify teretoxins arises from only a few different species and a limited 
number of toxins, evaluation of the presence and degree of post-translational modification remains 
speculative.  To address the issue of PTMs in terebrids it is important to increase the database of 
annotated transcriptome proteins, one of the outcomes of this work, and then confirm these findings on 
the proteomic level. 
 Overall there is still much work to be done to characterize the composition, structure and function 
of teretoxins. Understanding features such as gene superfamily organization, disulfide connectivity, and 
the presence or absence of post translational modifications will be essential in carrying this work forward.  
Combining proteomic and genetic analysis with the advanced techniques now available, in particular the 
latest advances in mass spectrometry and next generation sequencing, promises to quickly advance our 
understanding of the particular characteristics of the terebrid species-abundant neuropeptides. 
1.6. Traditional vs. emerging techniques for venomic characterization 
 In the early days of research on the bioactive components of cone snail venom, dating back to 
the 1970’s, the traditional approach was “bioactivity guided fractionation.” This process begins with the 
extraction of crude venom from the snail either by dissecting the whole duct or milking the pure venom, 
performing an extraction process in acetonitrile and subjecting this product to reverse phase HPLC for 
venom fractionation.49  Isolation and selection of major peaks are then used for bioactivity guided assays, 
in particular intracranial injection into mice for evaluation of unusual behavioral phenotypes. In this 
approach, once a bioactive component is identified the peptide of interest may then be reduced, alkylated 
and sequenced via Edman degradation, or using newer methods, mass fingerprinted and de novo 
sequenced with mass spectrometry. Bioactivity guided fractionation has served to identify a number of 
conotoxins of clinical and biological interest, despite the drawbacks of being time consuming, labor 
intensive and expensive, it also requires many animals to get the requisite amount of venom. For smaller 
specimens, where the amount of sample venom duct material is minimal, the bioactivity guided 
fractionation approach becomes impracticable. Recent technological advances have enabled the 
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expansion of venom characterization to previously unsuitable specimens, broadening the reach of novel 
peptide toxin discovery and drug development. This emerging area is referred to as ‘Venomics’ and 
combines patterns in phylogeny and evolution with innovations in mass spectrometry and genetic 
sequencing.24,49–55 
1.6.1. Proteomic elution of venom components using mass spectrometry 
Venomics, in the case of sample limited material, and more generally as a comprehensive approach 
to performing whole venom analysis to identify as many components as possible, the field of peptide toxin 
discovery employs an integrated platform that combines emerging and powerful techniques to analyze, in 
concert, both the venom duct proteome and transcriptome (Fig. 6).56–58 Driving the proteomic efforts is  
 
Figure 6. Integrated pipeline for peptide toxin discovery. Transcriptomic and proteomic analyses are 
increasingly combined to identify novel peptide toxins with transcripts matching across platforms for 
database validation. 
increased sensitivity, accuracy and resolution of various types of mass spectrometry and the use of matrix 
assisted laser desorption (MALDI-TOF) and electrospray ionization (ESI) technologies coupled with liquid 
chromatography.55  Developments in the area of tandem MS (MS/MS) assisted in surmounting obstacles 
to de novo sequencing, which typically was performed with collision activated dissociation (CAD). The 
incorporation of newer techniques such as electron transfer dissociation (ETD), along with chemical 
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derivatization of cysteine residues to increase peptide charge state, have enabled more accurate 
reconstruction of longer peptide sequences than achievable through CAD alone.54,59 
In spite of these advances, de novo sequencing with mass spectrometry to obtain peptide primary 
structure is a difficult exercise, and integrating information from cDNA libraries and/or next generation de 
novo transcriptome assembly can facilitate the process significantly. For example, genetic sequencing is 
capable of identifying the full precursor structure of a toxin transcript, rarely achievable on the proteomic 
level, whereas the identification of posttranslational modifications still relies on proteomic analyses of the 
peptide itself. 
1.6.2. Next generation sequencing applied to venom characterization 
Advances in next generation sequencing technology over the last decade can only be described as 
revolutionary.60–62 Until recently, much of the genetic research to characterize the venom duct 
transcriptomes of marine snails has relied on the construction of cDNA libraries.63,64  This process begins 
with many of the same elements used in next generation sequencing, that is, the extraction of total RNA 
from the venom duct, followed by reverse transcribing the mRNA content into cDNA.  In some cases, 
specific primers may be designed to target specific peptide toxin transcripts of interest, but more often 
primers targeting the polyA tails of all mRNA transcripts have been used to obtain as many peptide toxin 
transcripts as possible. Cloning into a bacterial host followed by plasmid extraction and Sanger 
sequencing is then used to obtain as many transcripts as possible.  The random nature of the process 
inevitably means that not all peptide toxin transcripts will be captured, with a bias towards the most highly 
expressed. Construction of cDNA libraries has served the venom discovery process well as numerous 
peptide toxin transcripts from a diverse array of species have been identified in this manner.  The 
drawbacks to cDNA library construction include the lack of completeness, high cost, and the time and 
labor intensive nature of the process. 
The advent of next generation sequencing owes a great debt to the genius of the late, great Frederick 
Sanger, who invented the technology in which dideoxynucleotides (ddNTPs) are incorporated into DNA 
synthesis as chain terminating inhibitors of DNA polymerase, making sequence reconstruction a viable 
endeavor.65  Next generation sequencing has advanced the Sanger technique, with several significant 
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alterations, which include the use of reversible terminating dNTPs in the sequencing by synthesis (SBS) 
reaction, and the ability to perform these reactions on a massively parallel scale.  Each type of next 
generation sequencing technology varies in its particulars, such as the exact nature of the sequencing 
reaction, error rates and the length of reads generated, but all hold in common the ability to generate a 
significant amount of sequencing data from astonishingly small amounts of starting material. 
Elucidation of peptide toxin coding transcripts in venomous organisms with NGS have been largely 
focused on RNA-seq technologies to perform whole transcriptome sequencing.66–72 For non-model 
organisms such as ours, obtaining as complete a snapshot as possible of the venom duct transcriptome 
has been favored over attempts to sequence full genomes given their large size and high repeat content, 
requiring huge amounts of data and a difficult assembly process.68,73–75 RNA-seq is a more lithe approach 
that gets the job done, in spite of the inherent challenges of de novo reconstruction in the absence of a 
reference genome. RNA-Seq provides the raw material for an assembly that can be analyzed for the 
presence of transcripts of interest either on its own, or ideally in combination with proteomics analysis.  
Advances in sequencing technology and assembly algorithms continue to improve the results obtainable 
for transcriptome reconstruction, especially where high read coverage allows for the capture of rare and 
alternatively spliced transcripts, enabling a more complete portrait of the transcriptome. 
1.6.3. Technical aspects of next generation sequencing  
A significant portion of the research that will be described here focuses on characterizing the terebrid 
venom duct transcriptome and has made use of the latest advances in high-throughput sequencing 
technologies and de novo assembly.  As such it is instructive to lay out the groundwork of how this 
process works in its broad strokes, and what some of the challenges are in achieving both good 
sequencing data and a high quality assembly.    
Given the efficiency of their sequencing technology, the low read error rates, and the generation of an 
enormous amount of data at a reasonable cost and quick turnaround time, Illumina technology has come 
to dominate the NGS field. While the details of the Illumina technology are proprietary, the overall scheme 
proceeds as follows:  after generation of cDNA from RNA starting material, the cDNA is randomly 
fragmented with a shearing process, and adapters are ligated to the fragment ends (Fig.7).  These 
16 
 
adapters are complementary to oligonucleotides that have been hybridized to the flow cell, providing a 
dense lawn of primers for adapter attachment at both ends. Bridge amplification for the generation of 
double stranded DNA, followed by denaturation to generate single stranded DNA, sets the stage for the 
sequencing by synthesis reaction to occur.  
 
Figure 7. Illumina sequencing preparation and workflow. Construction of cDNA library from tissue-
extracted RNA, and subsequent steps to prepare DNA (shearing and adapter ligation), prior to application 
to Illumina flow cell, cluster generation and sequencing by synthesis (SBS).  
Sequencing by synthesis includes all four fluorescently labeled, reversibly blocked dNTPs, primers, 
and a DNA polymerase for the incorporation of one base per sequencing cycle.  Excitation and 
fluorescent emission allow the recording of each base incorporated into the growing chain, with the cycles 
repeated until a segment of defined length has been sequenced.  With Illumina HiSeq technology, one of 
their most utilized applications, the sequencing length has reached a maximum of 150 bp.  Illumina 
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sequencing is also designed to allow for paired end sequencing. In other words, clusters are regenerated 
after the first sequencing round so that both ends of the template molecule may be sequenced,  
It is remarkable to note that solid phase amplification on the Illumina flow cell surface allows for 1000 
copies per single template molecule, with a proximity of one micron or less between clusters, leading to 
the generation of 10 million clusters per centimeter squared. In 2007 a single sequencing run could 
generate a maximum of 1 GB of sequencing data, and by 2011 this number increased to 1TB of data, a 
thousand fold increase.  In 2014, Illumina released the HiSeq X 10, designed primarily for the purpose of 
sequencing an individual human genome, which can generate up to 1.8 TB of data in the space of three 
days and also achieved a much anticipated low price of $1000 per genome. 
1.6.4. Bioinformatics tools for de novo assembly and analysis 
Having a robust amount of high quality sequence data is an excellent first step on the road to 
studying a transcriptome or genome of interest, but in reality it is only the very beginning of a journey that 
requires many strategic decisions about assembly and analysis, given the biological questions under 
consideration and the many choices of bioinformatics tools that can help achieve specific goals.76,77 In 
step with the advances of next generation sequencing technologies, the computer programs designed to 
assemble the data have also had to evolve. Today the researcher is confronted with numerous software 
options, and it is often necessary to try multiple approaches for comparative and evaluation purposes. 
The outcome of a de novo transcriptome assembly is a set of contigs, or “contiguous assembled pieces of 
DNA” that are representative of the transcripts coding for peptides and proteins of interest.  Contigs are 
dependent on the assembly process and require further analysis to mine for the open reading frames that 
provide a basis for gene prediction. Assembly programs are designed to take raw reads and use specific 
algorithms to reconstruct as faithfully as possible the global genetic information from which the 
sequencing data was derived, but inevitably there are errors in the assembly process that lead to 
fragments and chimeric sequences that in addition to the well assembled contigs tend to inflate the 
assembly.  Part of the challenge of de novo assembly in the absence of a reference genome is to identify 
and validate contigs as being truly representative of genes of interest.  
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The assembly process most often applies graph based reconstruction approaches that fall into 
two camps, overlap layout consensus (OLC) or de Bruijn methodologies.78,79 The OLC approach 
computes pairwise overlaps between reads and builds these into a graph that takes into account the 
global relationships among the reads.  OLC is a traditional approach that is tailored towards longer reads 
where pairwise overlaps can be assessed with a reasonable degree of confidence, and was initially 
developed for handling Sanger sequencing in the early stages of piecing together the first human 
genome.80   While it is still used in software programs such as Mira for the assembly of 454 and other 
long reads, it does not scale well with an increasing number of short reads and becomes too 
computationally intensive for practical application.  
With the arrival of sequencing technologies such as Illumina HiSeq, capable of generating 
hundreds of millions of reads that are typically 100 bp in length, developers of assembly programs turned 
towards the de Bruijn graph based approach to tackle the computational problem of assembly.81–83 In this 
approach, reads are subdivided into kmers of a specified length, which can vary depending on the 
number specified by k (Fig. 8).  Each kmer successively overlaps the entire length of the read by itself  
 
Figure 8. De Bruijn graph methodology. Simplified overview of De Bruijn graph approach to assembly 
with kmer of length 7.  Each read is subdivided into kmer of with an overlap of length k-1.  Independent of 
the reads themselves, assembly requires that each kmer ‘node’ is an exact overlap of k-1 with a directed 
edge connecting successive kmers (http://www.homolog.us/blogs/blog/2011/07/28/de-bruijn-graphs-i/) 
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minus 1 (k-1), so that the kmer itself “slides” forward by one base across the read with each additional 
kmer.  Once all the reads have been subdivided, the kmers themselves are used for graph construction, 
independent of the reads, by searching for exact overlaps of length k-1.  Each unique kmer represents a 
node and an exact overlap represents an edge.  As these connections are built up, genetic sequence can 
be reconstructed, one base at a time.  However, as there are many potential paths that could be followed 
in finding these exact matches, the graph can become enormously complex, and the ultimate task is to 
traverse and compress the graph as correctly as possible while resolving alternatives that arise from true 
SNPs vs. sequencing errors, as well as numerous other stumbling blocks.66 
 Software programs such as Trinity and Velvet Oases are based in the de Bruijn graph approach, 
and are some of the most widely used programs for de novo assembly.84,85 As read quality continues to 
improve and new versions of these assembly programs are released, it is possible to acquire more 
accurate assemblies even in the absence of a reference transcriptome or genome.  The current tendency, 
even for Illumina, which has specialized in producing shorter reads at high volume, is to generate ever 
longer reads.  It will be interesting to see how the underlying algorithms of assembly programs will 
respond to these developments, and if ultimately there will be a return to an OLC approach, or if other 
computational alternatives will be explored.  Historically, longer reads have shown significantly higher 
error rates, but this is destined to change as the technology keeps improving. Staying abreast of new 
developments both in terms of sequencing technologies and the software tools available to analyze data, 
not only for assembly, but for all the other facets of downstream analysis, is crucial to obtaining the best 
outcomes possible for the faithful reconstruction of either transcriptomes or genomes. Once a transcript 
sequence has been validated it is then possible to synthesize the peptide and apply it to biological assays 
to investigate its function. 
1.7. Synthesis strategies for neuropeptides 
As outlined above, identification of potential peptide toxins can be determined either from direct 
venom faction of the primary sequence (proteomics) or by genetic sequencing of the venom specific 
tissue (transcriptomics).  As with all roads leading to Rome, identification of the toxin sequence, no matter 
how this is achieved, leads to chemical or recombinant synthesis of the peptide for application to 
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functional assays. Unlike milking snakes, conoidean snails produce significantly less venom, and effective 
functional characterization is greatly enhanced by synthetic peptide synthesis to obtain sufficient 
quantities for bioactivity assays. Choices for cysteine rich peptide synthesis fall into two camps, either the 
chemical method of solid phase peptide synthesis (SPPS)86, or by taking advantage of nature’s 
machinery for recombinant expression of the peptide in a bacterial or other type of living host.87  
There are pros and cons to SPPS and recombinant expression of peptides, and the choice is 
generally dictated by features such as the presence or absence of post-translational modifications, the 
peptide length, and biochemical properties. For conotoxins, which tend to average close to 30 amino 
acids in length, as well as carrying numerous post translational modifications, SPPS is directly suited to 
their synthesis.88 However, SPPS becomes increasingly difficult and expensive with increasing length of 
peptide, and longer peptides may require chemical ligation reactions that are often problematic.  In the 
case of longer peptides that lack post translational modifications, recombinant expression in heterologous 
systems offers an attractive alternative, with the most common approach being expression in an E. coli 
host. 
1.7.1. Solid phase peptide synthesis (SPPS) of venom peptides 
SPPS is a chemical synthesis technique pioneered by Robert Merrifield in the 1960s and for 
which he received the Nobel Prize in 1984.89 The major breakthrough for improving the synthesis process 
was conducting the reaction on a solid support, or resin, rather than in the liquid phase. With the use of a 
solid phase, the first amino acid is attached at its C-terminus to a resin via a linker, and subsequent 
elongation of the peptide is immobilized on the support until cleavage. The basic cycle of synthesis 
involves repeated rounds of amino acid couplings and deprotection, washing away excess reagents 
between steps.  Every amino acid that is incorporated into the growing polypeptides carries a N-terminal 
protecting group that must be removed prior to coupling, while the addition of an activating group 
facilitates the formation of the peptide bond (Fig. 9). 
The two major approaches to SPPS are acid labile and base labile, with the latter being favored in many 
life science laboratories for the use of less hazardous reagents and overall milder conditions.90 Base 
labile synthesis is referred to as Fmoc (9-flourenylmethyloxycarbonyl) SPPS. Fmoc is a protecting group 
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that shields the alpha amino group from unwanted side reactions until it is deprotected under basic 
conditions in piperidine and Dimethylformamide (DMF). Fmoc also has the advantage of allowing for the 
use of acid labile protecting groups for amino acid side chains, as the Fmoc cleavage takes place under 
very mild basic conditions that are generally not reactive towards these groups.  Upon completion of 
peptide synthesis, cleavage of the peptide from the resin is performed with trifluoroacetic acid (TFA). In 
contrast, Boc SPPS requires special equipment for cleavage from the resin using anhydrous hydrogen 
fluoride (HF). Upon completion of SPPS, the linear peptide requires the subsequent step of oxidative 
folding in which the formation of disulfide bonds is promoted by air oxidation and enhanced by a mixture 
of disulfide exchange shuffling reagents such as oxidized/reduced glutathione or other low molecular 
weight thiols.91  
Many improvements have been implemented since the early days of SPPS, including optimization of 
resins, linkers, protecting groups and activating groups, as well as automated options, yielding a wide 
array of options to obtain the desired peptide sequence.92   Automated synthesizers and the variety of 
technologies behind them have helped to revolutionize the field in terms of both speed and labor.92 SPPS 
will undoubtedly continue to be the predominant approach to the synthesis of marine snail peptide toxins 
given its effectiveness for the synthesis of short peptides in high yield.  Even so, there is still a useful role 
for recombinant expression in synthesizing toxins of interest, especially for longer peptides or those that 
prove difficult to synthesize under synthetic chemical conditions.  
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Figure 9.  General scheme for Fmoc Solid Phase Peptide Synthesis. Synthesis process is based in 
rounds of deprotection, activation and coupling until final product is cleaved from resin. 
(http://www.sigmaaldrich.com/content/dam/sigma-aldrich/life-science/solid-phase-syn-schem.gif) 
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1.7.2. Recombinant expression of neuropeptides 
Recombinant DNA technology has enabled scientists to produce a large number of diverse 
proteins, in various types of prokaryotic or eukaryotic hosts, which were previously unavailable, relatively 
expensive, or difficult to obtain in quantity.93 Escherichia coli (E. coli) bacteria is a primary host for the 
cloning and expression of proteins of interest, however other eukaryotic systems, such as yeast or insect 
cells, have also been used effectively for the same purpose.  Harnessing nature to do nature’s work has a 
certain appeal, and it is remarkable the extent in which the genetic machinery of microorganisms can be 
manipulated with the introduction of foreign genetic material put under the control of an inducible 
promoter. The overarching scheme for recombinant expression of disulfide rich venom peptides requires 
a gene construct coding for the peptide of interest, a vector of choice, and an expression host (Fig. 
10).94,95  
Figure 10. Scheme for recombinant expression of disulfide rich venom peptides. Major steps for 
expression of a disulfide rich peptide in an E. coli host with an emphasis on achieving solubility and folding. 
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Performing expression in E. coli has the advantage of several vectors and host strains that have been 
developed for maximizing expression while remaining economically attractive.  Currently there are also a 
wealth of options for the molecular cloning step of inserting a gene construct into a plasmid vector that 
are more efficient and reliable than a traditional restriction enzyme approach.94,96 
For many years the standard technique for inserting a gene into a plasmid has begun with PCR 
amplification of the gene to introduce restriction enzyme sites that are subsequently cut with the enzyme 
to generate “sticky ends” for ligation into a plasmid. The multiple cloning site (MCS) of a given plasmid 
vector offers many types of restriction enzyme sites given the need to identity unique cleavage sites at  
the ends of the gene insert.  Both insert and vector are treated with the same enzymes to generate 
matching overhangs that can be stitched together in a directional orientation upon the addition of DNA 
ligase. While the restriction enzyme method is certainly functional, the success rate can be relatively low 
given the variable efficiency of restriction endonucleases, and may require multiple attempts to ensure 
that the gene is inserted correctly in frame into the vector of choice.94 
In response to the difficulties encountered with restriction enzyme cloning, a variety of alternative 
techniques have been developed over the last several decades to improve the efficiency and speed of the 
important first step of recombining insert with vector.  One such method is TA cloning, based in the 
addition of adenines to PCR amplified inserts via Taq polymerase activity, which may then be ligated into 
a plasmid vector carrying thymine extensions.96,97  While this method is simpler and faster than restriction 
enzyme cloning, and can be made especially rapid with the addition of topoisomerase as the ligase 
(TOPO-TA), the major drawback is that this type of cloning is not directional. 
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The development of ligation independent cloning (LIC) is an efficient process that has freed the 
molecular cloning process from the use of restriction enzymes and provides for directional cloning.98,99 
LIC takes advantage of the simultaneous exo and endonuclease capabilities of T4 DNA polymerase to 
generate complementary 10 to 15 base pair overhangs on both insert and vector that enable hybridization 
by a simple annealing process (Fig. 11). The LIC approach requires that the flanking sequence at insert 
and plasmid terminal ends contain only three of the four possible nucleotide bases, so that the 3-5' 
exonuclease activity of the polymerase in the presence of a single dNTP corresponding to the missing 
base balances polymerization against base removal until a single stranded overhang of a specific length 
is generated. This process depends only upon the sequence of the flanking regions, and is independent 
 
Figure 11. Ligation-Independent Cloning (LIC) strategy for recombinant expression of venom 
peptides. An efficient process for directional cloning based on the generation of long single “sticky ends” and 
subsequent annealing into vector (image adapted from Novagen Xa/LIC Cloning Kit Protocol). 
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 of the coding sequences of the target gene and the functional sequences of the vector.  Control over the 
length of the flanking regions allows for directional cloning, and the extended length of the overhangs 
enables ligase free hybridization of insert and vector for circularization of the plasmid.  
Finding the most streamlined and effective approach for molecular cloning sets the stage for 
transformation into the bacterial host and ultimately, expression of the peptide or protein with attention to 
maximizing yield. The overexpression of cysteine-rich peptides can lead to problems with either 
proteolytic degradation or aggregation, and the undesirable formation of inclusion bodies.  Choosing an 
environment favorable to disulfide bond formation is an important consideration in experimental design in 
order to circumvent the typical reducing environment found in many E. coli host strains.100,101 To facilitate 
folding and avoid peptide aggregation, cysteine-rich peptides are often expressed in conjunction with 
carrier proteins that remain soluble and express at high levels.102,103  Examples of these carrier proteins 
include maltose binding protein, glutathione S-transferase, and thioredoxin, with the latter having the 
advantage of facilitating disulfide bond formation. 
Peptide expression as part of a larger fusion construct requires that a cleavage site be 
engineered into the gene construct for release of the peptide from the carrier protein post-expression.  
There are a number of options for the insertion of a cleavage site for proteolytic processing, including 
enterokinase, factor Xa, TEV protease and thrombin.  While any of these may be used successfully for 
cleavage, a problem that may arise is non-specific cleavage, or limited access to the cleavage site due to 
protein structural features, and consequent low yield of final product.88 The use of proteolytic enzymes 
can also add significantly to cost, and has led to the development of alternative methods such as the use 
of segments of proteins that are able to excise themselves by a self-catalytic mechanism (inteins). For 
recombinant expression work, inteins have been modified to undergo temperature and pH dependent 
cleavage of only the peptide bond between the C-terminus of the intein and the start of the downstream 
target protein, allowing for its release.104,105 
The aspects of recombinant expression described here only begin to scratch the surface of options 
for obtaining a disulfide rich peptide of interest in sufficient yield while optimizing conditions for folding and 
solubility.  A number of different conopeptides, as well as peptide toxins from scorpions, spiders sea 
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anemone have been successfully expressed in E. coli using a variety of approaches.103,106–109    In cases 
where soluble protein cannot be obtained, the use of strong denaturing reagents and subsequent 
refolding have been necessary. Recombinant expression will undoubtedly continue to play a role in the 
production of longer neuropeptides, not only in E. coli but also in eukaryotic systems such as the yeast 
strain P. pastoris, which are inexpensive to grow in culture, while providing an intracellular folding 
environment similar to that of mammalian cells.110,111  With some effort  it is possible to incorporate 
unnatural amino acids in recombinant systems, using a unique codon-tRNA pair and corresponding 
aminoacyl synthetase to recombinantly expressed modified or unnatural amino acids at specified sites in 
venom peptides112   
1.8. Characterization of venom peptide bioactivity 
Preliminary characterization of conoidean peptide toxins of interest is typically conducted via a 
phenotypic assay, such as intracranial injection in mice as pioneered by Olivera and colleagues28, or 
teretoxin injection into prey organisms such as Caenorhabditis elegans (C. elegans).47 Injection of 
bioactive conoidean peptides into a mouse brain or prey organism elicits a phenotypic response that 
provides a global indication of function. Worm assays in both leech and C. elegans have been used to 
verify peptide toxin effects on behavioral activity, and changes in movement analyzed with the use of 
computer tracking algorithms can provide a quantitative assessment of motion changes such as paralysis 
or uncoordinated behavior.113–115 
To identify the specific target of a peptide toxin in the nervous system a gamut of approaches can be 
applied, including classical methods such as two electrode voltage clamp or patch clamp 
electrophysiology performed in a variety of cell types, including mammalian DRG neurons and HEK cell 
lines.116–118 One widely used approach for electrophysiology studies is the heterologous expression of ion 
channels that is performed with either transfection of genes into tissue culture cells or with the injection of 
genetic material (cDNA or mRNA) into the larger egg progenitor cells (oocytes) of the African frog, 
Xenopus laevis119. Today the oocyte model is still widely in use since its development in 1982, due to the 
reliable expression of genes coding for ion channels, their large size, and the absence of endogenous ion 
channels that would complicate electrophysiological recordings for a target channel. However, this 
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approach is time and labor intensive in cases where there is little information of the type of ion channel or 
ligand-gated receptor targeted by a novel uncharacterized peptide toxin, such as the ones discovered in 
this dissertation.   
In an interesting twist on the oocyte approach, Dr. Ibañez-Tallon and colleagues developed a 
tethered-toxin method that takes advantage of some novel qualities of Lynx-1, a membrane-bound 
prototoxin identified as a modulator of the nAChRs in mammalian neurons.120 In short, recombinant 
expression is used to build a tethered-toxin construct where the Lynx-1 prototoxin sequence is replaced 
with a sequence coding for the neurotoxin of interest. Lynx-1 is bound to the membrane with a 
glycophosphatidlyinistiol (GPI) anchor or transmembrane domain, ensuring the peptide is close to its 
molecular target. This modular system in principle allows for various peptide toxins to be inserted into the 
Lynx-1 scaffold and screened for activity in electrophysiology assays.121 
Beyond a classical electrophysiology approach to elucidate novel peptide toxin function, other 
techniques to assess changes in membrane potential include radioligand competitive binding assays, the 
use of ion sensitive fluorescent dyes and ion flux assays.122–124  Alternative approaches have been useful 
to profile compounds of interest, including conotoxins,125 but provide only indirect measures of ion 
channel activity. The need for high-throughput ion channel screening utilizing electrophysiology has led to 
the development of a variety of automated platforms for screening compounds in mammalian cell lines 
and oocytes.126  Recently described high throughput approaches may help to overcome the labor-
intensive and slow nature of patch clamp electrophysiology, so that novel venom peptides may be 
screened more rapidly and efficiently for drug discovery and development. 
1.9. Objectives of Thesis Project  
The primary focus of this research has been to apply a venomics approach via state of the art 
genetic techniques to characterize novel neuropeptides found in venom duct transcriptome of terebrid 
marine snails, and to use this information to synthesize peptides of interest, using either chemical or 
recombinant strategies, in sufficient quantities for bioactivity assays. Characterization of the venom duct 
transcriptome made use of next generation sequencing in combination with a range of bioinformatics 
tools for de novo assembly and analysis to identify as many terebrid toxin transcripts as possible from two 
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terebrid species, C. anilis and T. subulata. This work highlights the ability of deep sequencing to surpass 
previous genetic efforts of cDNA library construction and Sanger sequencing at peptide toxin 
characterization. De novo assembly in the absence of a reference genome requires the deployment of 
several bioinformatics tools to achieve the best results, and a significant effort has been made to utilize 
multiple approaches for cross validation of results and achieve the highest degree of accuracy possible in 
terebrid venom duct transcriptome reconstruction. The teretoxin transcripts identified herein have been 
evaluated in the context of the large body of research regarding the genetic organization, structure and 
function of conotoxins, the closest evolutionary relative.  In characterizing venom peptides from terebrid 
transcriptomes, an analysis of non-toxin genes was conducted, using homology based searches to 
categorize transcripts by gene ontology function and obtain a global portrait of the highly specialized 
venom duct tissue and the evolution of convergent and divergent venom compounds. 
A further goal of this research has been the synthesis and folding of select terebrid toxins to 
obtain sufficient quantities for characterization of bioactivity. The two major methods used were solid 
phase peptide synthesis (SPPS) and recombinant expression. While solid phase peptide synthesis has 
been the method of choice for synthesizing conotoxins for the last several decades, due to the longer 
residue length of teretoxins, which can be intractable using SPPPS, the focus here has been on the 
optimization of recombinant expression for the expression of disulfide rich peptides that are not amenable 
to chemical synthesis.  The ultimate goal of teretoxin synthesis has been to provide a sufficient quantity 
for bioactivity assays, and perform preliminary tests of bioactivity, such as a phenotypic worm assay. 
The research outlined in the remaining pages of this dissertation relay the first comprehensive 
genetic analyses of Terebridae venom peptides. 
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Chapter 2 
De novo characterization of Terebrid 
venom duct transcriptomes 
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2.1. Background: a revolution of model systems 
In the postgenomic era the concept of a model system is rapidly evolving. Customary model organisms 
such as D. melanogaster, C. elegans, and M. musculus, while still gold standards, no longer corner the 
market, and it is possible with ever advancing sequencing techniques to literally scrape the ocean floor for 
organisms that produce novel genes and gene products. Previously unsuitable organisms, due to size, 
availability, or gene complexity, are being investigated at an increasing pace because of their unique 
qualities and the possibility of identifying novel ligands for understanding the molecular basis of biological 
processes.127 With decreasing costs and increasing technology, molecular and functional genomics 
studies enable venomous organisms to become model organisms in the drug discovery arena. In the 
search for new drug discovery model systems, marine conoidean organisms are leading the charge. The 
enormous diversity of conoidean venom peptide toxins greatly outnumber that of snakes, a prior 
pharmaceutical industry favorite due to ease of collection and venom milking capabilities.128 This thesis 
project applies next generation sequencing techniques to study the venom duct transcriptome of 
Terebridae marine snails, to characterize terebrid unique features in comparison to cone snails, 
particularly as it pertains to elucidating novel genes and gene products that can be used to manipulate 
cellular communication for the development of new therapeutics.   
As high throughput sequencing technology and computational methods continue to improve, the 
accurate reconstruction of complex venom duct transcriptomes is accelerating at an equal rate, even for 
venom duct tissue only available in vanishingly small amounts. Previous cone snail venom duct 
transcriptome surveys have produced results that are pertinent to drug discovery and development, such 
as identifying new venom gene superfamilies and peptide toxin ligands.70,71,129 Interestingly, the majority 
of recently published studies on venom duct transcriptomes of cone snails and snakes have used Roche 
454 sequencing. 68,71,72,130,131 The bias towards 454 technology in venomics research has likely resulted 
from the long average 454 read length, which has the potential to cover an entire peptide transcript prior 
to assembly.  454 technology, however, is hindered by low read coverage and a high error rate especially 
with respect to indels. Illumina technology was chosen to generate high throughput terebrid venom duct 
transcriptome sequencing data for this thesis. Compared to 454 Illumina has better read accuracy and far 
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superior depth of coverage. Longer read lengths, depth of coverage, and deployment of ever expanding 
bioinformatics tools allow unparalleled insight into the diversity of animal venom peptide transcripts. It 
should be noted that de novo characterization of a transcriptome, in the absence of a reference genome, 
continues to be a challenge, but specific measures may be taken to improve the confidence level of 
transcripts by strict assessment of read quality, the right choice of assembly tools, and comparison of 
results among different bioinformatics programs to validate results.66,76  
The first de novo assembly and analysis of terebrid venom duct transcriptomes using RNA-seq 
are presented in this work. Two species of terebrid were selected for characterization, Cinguloterebra 
anilis (C. anilis) and Terebra subulata (T. subulata).  Both are vermivorous (worm hunting) species that 
similar to cone snails, uses a sophisticated venom apparatus to inject venom into prey via a hollow, 
harpoon shaped radular tooth (Fig. 1). Not all terebrid snails have a venom apparatus to subdue their 
Figure 1. Terebridae shell and venom apparatus schematic. A. Photo of Cinguloterebra anilis and 
B. Terebra subulata.  C. Illustration of conoidean venom apparatus with salivary gland (sg) venom 
gland (vg), muscular bulb (mb) and radular sac (rs) D. SEM of radular tooth from Terebridae clade C 
(Venom apparatus illustration and SEM image courtesy of Yuri Kantor) 
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prey. In 1970, Miller  
characterized three different hunting physiologies for the Terebridae.132 Recent studies have facilitated 
the identification of terebrid lineages that produce venom for prey capture by correlating the molecular 
phylogeny of the Terebridae to the evolution of its venom apparatus (Fig. 2).53,133,134 Using this 
biodiversity derived discovery approach C. anilis and T. subulata were selected for venom 
characterization. Both C. anilis and T. subulata are part of the Terebra genus (Clade C), in which all 
species of terebrid have a venom apparatus (Fig 2). 
 
The primary goal of terebrid transcriptome research is to characterize disulfide rich peptides expressed in 
the venom duct in order to identify ligands that may be subsequently used to manipulate signaling in the 
nervous system. This research has also been designed to provide an assessment of other proteins 
expressed in the terebrid venom duct and to organize identified proteins by function with gene ontology 
(GO) and enzyme (KEGG) classifications in order to enhance the knowledge set of venom genes for 
model system comparative analyses. Finally, this work establishes a robust bioinformatics pipeline that 
runs the entire gamut of sequencing and analysis that can be applied to ongoing research on other 
terebrid specimens (Fig. 3). 
Figure 2. Venom apparatus characterization in the Terebridae. The presence or absence 
of venom duct (gland) mapped to the molecular phylogeny of the Terebridae. (Castelin et 
al., 2012) 
 Figure 3. Bioinformatic pipeline for obtaining and characterizing terebrid venom duct 
transcriptome data. The outlined work flow is based on tissue preparation and Illumina sequecing 
(Phase 1). Upon obtaining sesquences, quality checks are performed (Phas
then assembled and evaluated (Phase I
(Phase IV).  
2.2. Results and Discussion 
2.2.1. Hi-Seq Illumina sequencing and overview of C. anilis transcriptome assemblies
Reconstructing a transcriptome with next generation sequencing technology requires several 
major steps that include extraction of RNA, construction of a cDNA library, high
and de novo assembly. Here total RNA extracted from eight poo
generate a polyA enriched cDNA library for sequencing on the Illumina HiSeq platform. A single lane from 
the Illumina flow cell generated 288,959,674 paired end reads of 100 bp length, which after quality control 
as described in materials and methods reduced the total number to 280,143,112 reads.
Given the large number of reads and high depth of coverage, digital normalization was applied to 
the trimmed reads prior to assembly with Trinity
size of the data, while retaining the information found in the full dataset by eliminating high
read data. This digital normalization technique also eases the computational burden of assembling 
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hundreds of millions of reads, reducing the time and memory requirements of de novo assembly, which is 
advantageous for performing multiple assemblies.135 In the case of Trinity, assemblies were constructed 
for both the full set of raw reads and digitally normalized reads.  Given the large memory requirements of 
Velvet Oases, de novo assemblies with this program were run only on digitally normalized reads, over a 
range of kmers from 25 to 55. Statistics for all assemblies are reported in Supplementary Table 1.     
A total of four assemblies, including Trinity assemblies and Velvet Oases assemblies run at 
kmers 25 and 51, respectively, were used for the identification of novel neuropeptides. The four 
assemblies are: 1. TrinDN (Trinity assembly from digitally normalized reads), 2. TrinAllReads (Trinity 
assembly run on full set of reads), 3. VO25 (Velvet Oases assembly run at kmer=25), and 4. VO51 
(Velvet Oases assembly run at kmer=51). Four assemblies were used to maximize the capture of putative 
teretoxins and for comparative analyses across assemblies to support the de novo assembly process. 
Assemblies that are run over a range of kmers, as is the case with Velvet Oases, may subsequently be 
meta-assembled using a tool such as CAP3, CD-HIT-EST, or program specific tools such as Oases 
merge.  However, the risk of meta-assembly lies in the artificial collapse of isoforms into one transcript 
and the potential for misassemblies, exacerbating the problem of chimeric transcripts already found in 
individual assemblies.136 Toxin transcripts may be particularly at risk for loss of discrete transcripts or 
chimeric assembly under the conditions of merging, as they are rich in isoforms that can vary from minor 
amino acid substitutions to increasing degrees of variability. The Trinity assembly of digitally normalized 
data was chosen as the primary tool for downstream analysis of C. anilis sequences, as the software is 
frequently updated and is specifically designed to capture transcript isoforms. 
2.2.2. Identification and validation of teretoxin transcripts 
Terebrids, like their cone snail counterparts, express a broad repertoire of highly variable, 
disulfide rich peptides. Precursor teretoxin transcripts contain a mature peptide toxin with a highly 
conserved cysteine (Cys) framework in combination with hyper-variable amino acids found in between 
cysteines. The abundance of peptide toxins in conoidean venom duct is believed to stem in part from high 
rates of gene duplication, while the hypervariable mature peptide region likely results from strong 
diversifying selection at specific loci, leading to significant allelic variation.17,18 Part of the challenge of 
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parsing a de novo assembly is identifying with confidence as many peptide toxin transcripts as possible. 
To begin this work, the four assemblies referenced above were blasted against a dataset of conotoxins 
downloaded from www.conoserver.org and an in house database of teretoxins representing a variety of 
terebrid species. Curation of these results yielded 84 putative teretoxins, which are organized by Cys 
frameworks using the same Roman numeral nomenclature as for conotoxins. A similar approach was 
applied to identify T. subulata toxin transcripts, using only one assembly, Trinity, on all reads. (Table 1). 
Table 1: Summary of C. anilis putative teretoxins 
Framework Cysteine Pattern 
C. anilis 
Transcripts 
T. subulata 
Transcripts 
Connectivity (cone 
snail) 
I CC-C-C 1 1 I-III, II-IV 
VI/VII C-C-CC-C-C 16 16 I-IV, II-V, III-VI 
VIII 
C-C-C-C-C-C-C-C-
C-C 16 13  
IX C-C-C-C-C-C 16 12 I-IV, II-V, III-VI 
XI C-C-CC-CC-C-C 2 2 I-IV, II-VI, III-VII, V-VIII 
XIII C-C-C-CC-C-C-C 5 2  
XIV C-C-C-C 4 1 I-III, II-IV 
XV C-C-CC-C-C-C-C 5 4  
XVI C-C-C-C  –  4  
XVII C-C-CC-C-CC-C 1 –  
XXII C-C-C-C-C-C-C-C 16 9  
XXV C-C-C-C-C-CC – 1  
Novel – 10 cys 
C-CC-C-C-C-C-C-
C-C 1 –  
Novel – 12 cys 
C-CC-CC-C-C-C-C-
C-C-C 1 –  
Total putative toxin transcripts:   84 
 
65 
 
 
For C. anilis, the 84 putative teretoxins that were identified comprise nine Cys frameworks that 
are known in conotoxins, and two novel frameworks of 10 and 12 Cys respectively. The diversity of Cys 
frameworks found suggests that teretoxins have a wide array of pharmacological targets. The 84 
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transcripts were analyzed for the presence of canonical peptide features as identified in conotoxins, 
namely the presence of a N terminal signal sequence, an intervening propeptide region ending with 
several basic residues identifying a cleavage site, and a C-terminal Cys rich mature peptide. Of the 84 
neuropeptide transcripts identified from BLAST results against the combined cono/teretoxin database, 64 
contain the full signal-pro-mature toxin canonical structure, and 20 have signal-mature sequence without 
a pro region, which also occasionally occurs in cone snails. 
To establish a high confidence level for the 84 newly identified teretoxin transcripts, where 
possible, the transcripts were cross-validated with all four de novo assemblies. A Venn comparison was 
used to identify multiple sequence alignments of the same putative peptide toxin identified separately in 
each assembly (Fig.4). In the best case scenario, transcripts have unequivocal support from all four 
assemblies, although it is possible for a transcript to be valid even if only identified from one assembly,  
 
Figure 4. Venn diagram showing overlap of putative toxin transcripts for Velvet Oases and Trinity 
assemblies. A. Comparative analysis of the four assemblies conduct on C. anilis transcriptome 
sequences.VO25 = Velvet  Oases assembly with kmer25. TrinDN = Trinity digital normalization assembly. 
TrinAllReads = Trinity assembly without digital normalization. VO51 = Velvet  Oases assembly with 
kmer51. B. Representative alignments of transcripts from all four assemblies that were used to generate 
Venn diagram. Levels of support range from all four assemblies to single assembly. 
 
since different assembly programs run with different parameters may be more effective at picking up 
specific transcripts where others fail to do so. For example, Trinity assembly algorithms are designed to 
tease out isoforms, while Velvet Oases assemblies constructed from both high and low kmer values 
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provide different parameters for coverage of both rare and more highly expressed transcripts.81,85 Venn 
analysis identified 27 transcripts with complete overlap in all four assemblies, indicating there is a high 
probability these are valid sequences.   
The disulfide rich proteins of venomous peptides present a complex array of cysteine (Cys) 
patterns in terms of both arrangement and number. Cys patterns are so important in conotoxins that they 
have been organized extensively by conserved frameworks, in association with conserved signal 
sequence, in order to better understand how gene families of peptides relate to pharmacological activity. 
Importantly, two identified C. anilis putative teretoxins have a novel Cys framework with respect to 
established cone snail frameworks. Can_10Cys, with the cysteine framework C-CC-C-C-C-C-C-C-C, and 
Can_12cys, with the cysteine framework C-CC-CC-C-C-C-C-C-C-C. Can_10Cys and Can_12Cys 
precursor structures have identical signal sequence and pro regions, while the mature toxin varies in 
terms of both cysteine framework and intra-Cys amino acid residues. Conotoxin classification has shown 
increasing evidence that gene superfamilies often associate with more than one Cys framework.37 With 
only two transcripts identified in this case, further analysis from other terebrid transcriptomes is required 
to determine if these complex associations between signal sequence and frameworks also holds true for 
teretoxins.  
The most prevalent neuropeptide transcripts identified in the four assemblies of C.anilis 
sequences fall into four different Cys frameworks (VI/VII, VIII, IX, and XXII), of varying number and 
pattern. The VI/VII framework of the O superfamily (C-C-CC-C-C) in cone snails, is the most heavily 
represented in C. anilis with 19 unique sequences with full precursor transcripts that include signal 
sequence, pro region, and mature toxin.  O superfamily conopeptides, which are active on Na+, K+, and 
Ca2+ channels, are also a predominant gene family in cone snail venom.70 O superfamily peptides 
produce immobilization and neuromusclar block in the prey by inhibiting ion channel flux.137 The other 
heavily represented Cys frameworks include: 15 precursor teretoxin transcripts of the 6 Cys framework IX 
peptides (C-C-C-C-C-C), 16 precursor teretoxin transcripts of the eight Cys framework XXII (C-C-C-C-C-
C-C-C ), and 16 precursor teretoxin transcripts of the ten Cys framework VIII (C-C-C-C-C-C-C-C-C-C). Of 
the four predominant Cys frameworks, VI/VII and VIII conotoxins are known to target serotonin receptors, 
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nAChRs, Na+, K+, and Ca2+ channels, while the molecular targets of frameworks IX and XXII are 
unidentified.   
Frameworks with five or fewer C. anilis teretoxin transcripts, include the eight Cys frameworks XI 
(C-C-CC-CC-C-C), XIII (C-C-C-CC-C-C-C) and XV (C-C-CC-C-C-C-C), the four Cys framework XIV (C-C-
C-C), and a single transcript for the four Cys framework I (CC-C-C). The low representation of the latter is 
somewhat surprising as Framework I peptides are ubiquitous in cone snails, and are known to frequently 
target nAChRs.138  Representative teretoxin transcripts for each Cys framework found in C. anilis 
assembly are illustrated in Figure 5, with alignment to its closest BLAST hit.   
 
 
Figure 5. Representative BLAST alignments of C. anilis teretoxin transcripts. Roman numerals on 
the right indicate the corresponding Cys framework assigned to each transcript. Alignments show 
homology of C. anilis toxins to the top blast hit, either to existing teretoxin or conotoxin, and conservation 
of cysteine patterns in mature toxins.  
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An interesting feature of the of C. anilis framework VI/VII peptides, is the repeated appearance of a 
conserved amino acid motif between the first and second Cys residues, best defined as PXY (Pro-X-Tyr), 
where X can be any intervening residue. An example of this is seen in Can.6.14, which has strong 
homology to a teretoxin (Tg77) previously identified from a Terebra guttata cDNA library (Holford, 
unpublished data). Similar to the ICK (Inhibitor Cysteine Knot) motif in conopeptides, the PXY motif may 
determine the structural and functional selectivity of teretoxins to their molecular target. Proline residues 
are known to affect the secondary structure of proteins.139  Unlike other amino acids, Proline is a 
secondary amine whose cyclic side chain provides rigidity to peptide chains that is usually represented by 
a ‘bend’ in structure.  Tyrosine residues have a reactive phenol (–OH) that can act as an acceptor of 
phosphate groups. Phosphorylation of phenol groups via receptor tyrosine kinases is a key feature of 
signal transduction processes.140 Proline and Tyrosine together in the PXY motif impart significant 
conformational and functional properties that may be important to teretoxin peptide function. Framework 
VI/VII conotoxins often target Na+, K+, and Ca2+ channels, but it remains to be seen if a similar pattern will 
emerge for teretoxins with a PXY motif.32 
As illustrated by Can.9.13, the 6 Cys framework IX teretoxins have structural features similar to 
conotoxins, namely a full precursor organization (pre-pro-mature) and tightly knit mature peptide resulting 
from a limited number of intra-Cys residues. Alternatively, framework VIII and XXII teretoxins display a 
precursor structure where signal sequence is either followed by a very short pro region or directly by the 
mature peptide. In addition, the mature peptide has more intra-cysteine residues than commonly seen in 
cone snails, resulting in a longer overall sequence. This alternative precursor structure is seen in 
Can.8.14 and Can.22.12. While the lack of a pro region is occasionally observed in conotoxins, the loss of 
this region in some teretoxin precursor transcripts raises interesting questions about the purpose of the 
pro region, which is currently not well understood, but is implicated in the protein disulfide assisted mature 
peptide folding process.141 The eight Cys framework XXII was only recently observed in conotoxins, but is 
quite prevalent in C. anilis transcripts. As noted above, the function of peptides with this framework is 
unknown. 
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Relatively few conotoxin sequences are reported for framework XI, (I superfamily) XIII (G 
superfamily) and XV (V superfamily) peptides, all of which contain 8 Cys in different conserved patterns.  
The I superfamily, composed of three subfamilies, is the best characterized in terms of pharmacology, 
with some conotoxins functioning as Na+ channel agonists and K+ channel modulators. Framework XIII 
conotoxins are extremely rare and have only recently been assigned to a novel G superfamily.142 These 
frameworks are all present in C. anilis  teretoxin transcripts.37  The representative framework XI sequence 
shown, Can.11.1, has its closest BLAST hit to a teretoxin identified from Terebra guttata, and as such 
differs significantly in sequence from its conotoxin counterparts. 
Several framework XIV transcripts are present in the C. anilis venom duct, with one in particular, 
Can.14.1, displaying a high degree of homology in the mature peptide region to asXIVa and VilXIVa 
conotoxins. This is the only example from this assembly of a teretoxin displaying such a high degree of 
homology to a conotoxin. Framework XIV conotoxins are a complex assortment of peptides classified into 
multiple superfamilies that include A,I2,J,L,M,O1, and O2.143 Several framework XIV conotoxins have 
been shown to elicit nAChR and K+ channel inhibition.144,145 Given its similarity to asXIVa and VilXIVa 
conotoxins, Can.14.1 was synthesized and an attempt was made to characterize its bioactivity (see 
Chapter 3). 
 Finally, a single C. anilis transcript with 16 Cys residues shows striking similarity to the 
conopressin/conophysin family of peptides identified from various cone snail species (Fig. 6). 
Conopressins (C-C) are short, nine residue peptides with two cysteines, which were originally discovered 
in the venoms of Conus geographus and Conus striatus, and have been characterized as 
vasopressin/oxytocin homologs based on their strong sequence similarity to these hormonal 
neurotransmitters.146 Despite the strong similarity to vasopressin, conopressin-T, isolated from the venom 
of Conus tulipa, has been shown to act as a V1-vasopressin receptor antagonist and a partial oxytocin 
receptor agonist, generating considerable interest in having conopressins serve as templates for drug 
design.147  
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The putative C. anilis conopressin-like transcript, identified here as “terepressin,” shares strong sequence 
homology with those identified from cone snails (Fig. 7). With such short constructs, it is possible for a 
single amino acid change to alter the affinity of the cono/terepressin for the receptor. This is the first such 
transcript to be identified from a terebrid snail, and it is a distinct possibility that other variations are 
present in other terebrid species that can be identified via transcriptome characterization.  
Where conopressins are among the shortest conopeptides identified, conophysins, which belong 
to the neurophysin peptide family, are one of the longest peptides ever identified in cone snail venom, 
with 14 cysteine residues (C-C-C-CC-C-C-C-C-C-CC-C-C) and 7 disulfide bridges.  Conophysins were 
first characterized as a major component in the venom of Conus radiatus, but no physiological role is 
Figure 6. Precursor structure of C. anilis transcript aligned to conophysin and conopressin sequences 
from cone snails. Conopressin and conophysin are expressed in one construct as demonstrated by 
alignment of C. anilis contig to recently identified, similar construct from C. geographus. 
Figure 7.  Alignment of a C. anilis terepressin to Conus conopressins.  Alignment of C. anilis 
conopressin-type (terepressin) sequence in alignment with all known conopressins.  
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currently understood for these peptides.  This C. anilis full precursor transcript provides evidence for 
cono/terepressin and cono/terephysin being expressed together, similar to vasopressin/neurophysin 
homologs from other organisms. While the terepressin portion of the transcript shows close homology to 
conopressin-G  (Fig. 7), the signal and terephysin sequences are much more variable compared to the 
signal and conophysin sequences of the full precursor structure recently identified in C. geographus (Fig. 
6)148.  Vasopressin/oxytocin hormonal neurotransmitters are emerging as viable targets for mental 
disorders, such as autism, social anxiety disorder, and schizophrenia.149 It is conceivable that co-
expression of vasopressin/neurophysin hormonal neurotransmitters may facilitate how they are regulated 
in biological processes.  
It should be noted that even when a potential teretoxin with a well-established conotoxin 
framework is identified in this study, the overall amino acid composition of the mature peptides is in most 
cases radically different from conotoxins in terms of identity, number and distribution of intra-cysteine 
residues (Fig. 8). As such, it remains to be seen whether teretoxins with the same conserved Cys 
frameworks found in cone snails will act upon similar ion channels and receptors. Given their significant 
differences from conotoxins, teretoxins may have novel molecular targets, thus identifying new 
mechanisms in drug discovery and development for therapeutic agents that modulate the nervous 
system. 
  
Figure 8. Circos representation of 
conotoxins. As illustrated by the increased number of BLAST hits of C. anilis putative toxins green lines) 
existing teretoxins compared to known cono
and specificity for neuronal molecular targets.
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C. anilis putative toxin blast results to known teretoxins and 
toxins (blue lines), they may have different functional selectivity 
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2.2.3. Preliminary analysis of Terebra subulata venom duct transcriptome 
Having established a working pipeline for characterization of the C. anilis venom duct 
transcriptome, a similar approach was applied to the venom duct transcriptome characterization of 
Terebra subulata (T. subulata). Reports in the literature have presented research on T. subulata primarily 
on the phylogenetic level, although a few of its venom components as well as some preliminary bioactivity 
have also been characterized.12,47,134,150 
As with C.anilis, the sequencing effort began with the pooling of four venom ducts and extraction 
of total RNA. Paired end reads of 100 bp in length were generated on the Illumina HiSeq platform, 
producing 176,799,164 raw reads with 92.42% having a quality score of Q30 or better. Further read 
quality assessment was performed as described above and the full set of reads was assembled with the 
Trinity program. Assembly generated 193,988 contigs > 200 bp in length, with an N50 of 924bp and an 
average contig size of 633 bp.  In addition to Illumina sequencing, the read data was augmented by 
performing 454 sequencing to take advantage of the longer read lengths. This sequencing effort 
generated 117,750 reads of average length 426.6 bp. 454 reads were assembled separately with the 
program Mira, which generated 9,464 contigs.  
The Trinity assembly of 454 contigs and 454 raw reads were blasted against an in house 
database of conoidean peptide toxins, which includes all teretoxins sequenced to date, including the C. 
anilis teretoxins, conotoxins, and any turrid or terebrid toxins reported in NCBI.  A first pass of combined 
BLAST results of all data yielded 65 putative T. subulata teretoxins in their full precursor structure, 
distributed across 11 cysteine frameworks. The initial T. subulata BLAST results accurately captured all T. 
subulata teretoxins either sequenced in house via cDNA work or those reported in the literature, 
confirming the quality of the T. subulata assembly and the integrity of the putative teretoxins identified 
thus far (Fig. 9). 
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Figure 9. Alignment of T. subulata toxins to previously identified teretoxins.  The T. subulata 
toxins identified from Trinity assembly in alignment to T. subulata toxins identified by cDNA cloning 
work (performed by M. Holford) or identified in the literature. 
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2.2.4. Comparative analyses of C. anilis and T. subulata venom duct transcriptomes 
Comparative analysis of the types and number of Cys frameworks found in C. anilis and T. 
subulata transcriptomes highlight strong similarities between the two venoms (Fig. 10). The most 
abundant Cys frameworks are VI/VII (C-C-CC-C-C), VIII (C-C-C-C-C-C-C-C-C-C), IX (C-C-C-C-C-C) and 
XXII (C-C-C-C-C-C-C-C), which confirm the tendency of teretoxins towards an increased number of Cys 
residues and generally longer peptides than those found in cone snails.  The absence of framework I 
peptides (CC-C-C) in T. subulata, as also seen in the C. anilis venom profile, is in striking contrast to the 
abundance of this category in conotoxins, where peptides of this framework are known to most frequently 
target nAChRs.  
 
Figure 10. Distribution of T. subulata and C. anilis toxins among different Cys frameworks. 
Comparison of how T. subulata and C. anilis Cys frameworks are distributed show a strong degree of 
similarity between the two venom duct transcriptomes. 
It may be argued that terebrids have evolved a different Cys framework to target ligand gated nAChRS 
given that these are a common target for venomous organisms and an effective target for quickly 
disrupting nervous system transmission. It remains to be seen what type of terebrid toxin this might be, 
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and whether it arises from a shorter cysteine framework as in cone snails, or from longer, more cysteine 
rich peptides.  
2.2.5. Identification of the first Teretoxin gene superfamily 
Identification of venom components from two different transcriptomes in combination with 
previous cDNA work done on other terebrid species have set the stage for the analysis of gene 
superfamilies that define the association between conserved signal sequences and specific frameworks 
(Fig. 5, chapter 1). At least 60% sequence identity in the signal peptide is the expectation for designating 
a superfamily. Investigation of one conserved signal sequence observed in different terebrid species has 
provided the basis for characterizing the first gene superfamily identified in terebrids (Fig. 11).   
Figure 11. Terebrid gene superfamily based on conserved signal sequence. The conserved signal 
sequence highlighted (pink bar) was used to identify the first gene superfamily for terebrids.  The 
conserved sequence is seen here in association with the six Cys framework C-C-CC-C-C, typical of the O 
superfamily in conotoxins. 
The conserved signal sequence, MATSGRLLCLCLVLGLVF (with minor variations) was identified in three 
different terebrid species, T. subulata, T. guttata, and C. anilis, in association with the six Cys framework 
C-C-CC-C-C.  In cone snails, this framework is found extensively in the O superfamily, although recently 
a new H gene superfamily has been defined with this framework present, based on venomics work done 
in Conus marmoreus and Conus victoria.58,72 Analysis of terebrid toxin signal peptides thus far has shown 
low homology with the signal peptides found in cone snails, but here there is an exception in so far as the 
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teretoxin signal peptide identified has strong sequence identity (>80%) with that of the H superfamily, as 
demonstrated by the alignment with H_vc7.2 from C. victoria (Fig. 11).  It is also interesting to note that 
while the mature peptide sequences diverge at many positions, there is 100% conservation of glycine at 
position 68, phenylalanine at position 74, aspartate at position 80 and leucine/isoleucine at position 85.  
To the best of our knowledge, no bioactivity has yet been investigated for the H superfamily, which was 
only recently been characterized.  
Identification of the first gene superfamily in terebrid toxins is an important breakthrough that 
frames the context in which teretoxins will be characterized.  
2.2.6. Identification of Teretoxin Transcripts with “Pepticomb” 
As terebrids and their toxins are in the preliminary stages of investigation, and currently have very 
low representation in public databases, it is important to have alternatives to BLAST as a means to 
identify putative toxin transcripts. To this end an in house software program, termed Pepticomb, was 
developed and used to analyze the C. anilis Trinity DN assembly. Pepticomb is largely based in source 
code kindly provided by the developers of the conoprec tool found on the conoserver website 
(www.conoserver.org).  The major objective was to use this code so that a conoprec type of analysis 
could be run as a standalone program on the large dataset produced by de novo assembly of the terebrid 
venom duct transcriptome. In stepwise fashion, Pepticomb examines a set of contigs for the presence of 
a signal sequence, looks for a pro-region that terminates in a basic residue cleavage site, and uses 
regular expressions to mine for permutations of Cys frameworks in the mature peptide with a limited 
number of intra-cysteine residues set by the user. Running this program on the Trinity DN assembly 
successfully identified all the putative teretoxins we identified via BLAST, as well as additional candidate 
toxins not identified in BLAST results.  These additional candidates include peptides of frameworks I, IX, 
VI/VII, VIII, XIII, XIV and XXII, which are Cys frameworks already present in the putative teretoxins 
identified via BLAST.  Pepticomb results also included candidate teretoxins of framework XII (eight Cys), 
framework XVI (four Cys), framework XVII (eight Cys), framework XXIV (four Cys) and two unknown 
frameworks with 10 and 12 Cys, respectively.  These latter candidate teretoxins with Cys frameworks not 
identified via BLAST sequence similarity search are shown in Table 2. 
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It is difficult without strong BLAST support for these additional peptides, especially given the 
inherent potential for misassembly or chimeric transcripts in de novo assembly, to present these as high 
confidence transcripts.  As such these results are not included in the final count of 84 putative C. anilis 
teretoxins peptides presented above, pending further verification by proteomic or other means. 
Nonetheless, Pepticomb is an important tool for exploring the frontiers not captured by BLAST, and is 
also extremely useful for organizing and validating putative toxin transcripts that are generated from 
BLAST results.  It is also ripe for further development with the incorporation of other alternatives to 
BLAST techniques, such as the use of the profile Hidden Markov Model (PHMM) to aid in the 
identification and classification of terebrid gene superfamilies, as has recently been done for 
conotoxins.72,151  
Table 2:  Pepticomb candidate toxins. These peptides were identified using pepticomb software to 
parse for signal sequence, pro region and cysteine framework. The algorithm is designed to identify 
toxins that may not be identified by BLAST-based homology searches.  
 Signal Pro region Mature peptide Framework 
comp43602_c1_seq15_1 MKTFIIVLATLLL
FPGLILG 
HPISGERRTPI
YKQER 
LRAVPGEEGGD C HTAYR C 
SDKA C KLQYRY C NEYY CC 
QESKKPALGLSTSPEHT C EL 
C KSH 
XII 
comp44060_c2_seq6_6 MSRMGAMLLVV
LLLLPWAAPSQ
EG 
EPDRRAEPRM
ATKR 
SVNHLNILRGISDVLPEN C S C 
DEYPK CC IYY 
XVI 
comp22024_c0_seq1_1 MMFRPTLLLTIL
LVSSMTMDSDG 
SMNEKRAAQG
PSKR 
C NND C DGRSDFKP CC 
DNSGK C LQFE CC LHGSTD 
C 
XVII 
comp30533_c0_seq2_1 MRLLLTVTLTML
TIMMMMTREVQ
P 
APAPLDSELHN
GQSAVDRSLP
RQKR 
AVSWGMKLL C LTPLRN CC 
GGRWG C Q 
XXIV 
comp42177_c0_seq1_5 MRSSLFVLLAVL
AVLAVLLDSNIA 
TDETLQR QNFEPRDA C GSQ C RR C 
SR CC QSTEKHGE C RSP C 
KR C QN C TGDADRG C 
Unknown: 10C 
comp43790_c0_seq16_2 MKPGFLLTFSLV
LTASILIFDAET 
ANHARLRRLIP
GRR 
DD C DTA C NT C NSER C 
NAPPDP C ATA C AE C TQ C 
QWGSGSSPIEKV C PT C NT C 
DR C PGRTRST 
Unknown: 12C 
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2.2.7. Annotation of teretoxin-related transcripts to other venomous organisms 
In the interest of exploring C. anilis venom duct transcriptome for genes outside of the scope of 
the short disulfide rich peptides categorized by Cys frameworks, a BLASTx search at an e-value cut off of 
1 e-10 was performed using the C. anilis Trinity DN assembly against the Uniprot animal toxin database, 
a highly curated database that includes venomous compounds from a variety of toxin producing 
organisms152. This search yielded BLAST hits to peptide toxins from a number of different toxin families, 
primarily found in snake and spider venom (Fig. 12). This search yielded BLAST hits to peptide toxins 
from a number of different toxin families, primarily found in snake and spider venom 
The greatest number of transcripts identified relate to the latroxin family of peptide toxins, which 
are high molecular weight compounds implicated in the presynaptic release of neurotransmitters such as 
acetylcholine by inducing neurotransmitter exocytosis.69,153 The latrotoxin family forms a major component 
of Latrodectus spider venom and comprises several types including alpha, beta, gamma, delta and 
epsilon-latroinsectotoxins. A recent analysis of the venom transcriptome of the black widow spider 
Latrodectus hesperus revealed the latroxin family to be highly diverse with a majority of the identified 
venom specific transcripts (39 in total) representing the latrotoxin family.154 
A number of C. anilis teretoxin transcripts with homology to acetycholinesterase were also identified 
from the comparative toxin BLAST.  Acetycholinesterase is a component of snake venom that rapidly 
degrades acetylcholine via hydrolysis.  Acetylcholinesterase is present in the Bungarus genus of snakes 
in large quantity, although it is unclear what role it might play in toxicity to prey.155,156 Other transcripts 
from the C. anilis transcriptome show homology to the toxin families of metalloprotease, phospholipase, 
prothrombin, ryncolin and CRiSP, components common to the venom of other organisms.157,158  While it 
would require further analysis to understand the role that these transcripts play in terebrid venom duct, 
and whether they have a significant effect on prey capture, analysis of the de novo terebrid assembly led 
to the identification of potential toxic components other than the classical short peptides that are better 
understood for their specific role in inhibiting nervous system transmission.  The latroxin type transcripts 
identified in our C. anilis assembly are potentially of the greatest interest, since they are the most 
prevalent and could have an important effect on pre-synaptic acetylcholine neurotransmission. 
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Figure 12. Comparative analysis of C. anilis venom duct transcriptome to other venom toxin-
related genes. A. Highlights similar venom peptides toxins identified. B. Venomous organisms with toxin-
related genes. 
2.2.8. Terebrid venom duct transcriptome annotation using Gene Ontology and KEGG  analyses 
In the interest of gaining an overview of non-venom related proteins present in the terebrid venom 
duct transcriptome, gene ontology (GO) analyses were performed on C. anilis transcriptome by combining 
BLAST results from the Trinity DN assembly against NCBI NR, Uniprot SwissProt, and Uniprot Trembl 
databases. BLAST2GO analysis led to the annotation of 13,055 contigs, which were then visualized with 
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WEGO according to second level GO classifications of cellular component, molecular function and 
biological process (Fig.13).  Compared to previous analyses of this type performed on the venom duct 
transcriptomes of cone snails and other venomous organisms (e.g. snake and spider), we have annotated 
significantly more transcripts (13,055), undoubtedly due to the substantial depth of coverage provided by 
our Illumina sequencing data.131,159 The large number of annotated contigs with GO terms indicate a 
robust de novo assembly of terebrid venom duct transcriptome. 
 
 
Figure 13. BLAST2GO annotation of C. anilis venom duct transcriptome assembly. BLAST2GO 
level 2 analysis annotates contigs according to cellular component, molecular function and biological 
process. The high number of genes identified confirms the robust de novo assembly of the C.anilis venom 
duct transcriptome.  
 
A high level of assembly coverage based on illumine data is also illustrated by the mapping of metabolic 
pathways using KEGG annotation and visualization of the associated pathways with the software tool 
iPATH (Fig. 14). In the case of the C. anilis transcriptome a preponderance of metabolic pathways are 
outlined, which compares favorably with a similar analysis of a C. geographus cone snail venom duct 
based in 454 data, where far fewer pathways were identified.130 
 
 Figure 14. Comparative iPath annotation of 
based tool that provides visualization of 
using approximately 120 KEGG (Kyoto Encyclopedia of Genes and Genomes
metabolic pathways from C. anilis illumina assembly. 
of metabolic pathways based on 454 assembly of the 
(Hu et al. 2011). 
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C. anilis and C. geographus metabolic pathways.
C. anilis metabolic pathways using a global pathways map 
) pathways. A.
B. Previous research effort presenting similar visualization 
Conus geographus, with annotation of fewer pathways 
 
  Ipath is a web 
constructed 
 Visualization of 
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Previous analyses of GO annotation have suggested that enrichment of proteins found within 
certain GO categories are related to specific functional aspects of the venom duct, in particular the 
potential high metabolic cost of toxin production. Such studies have suggested that the high 
representation of proteins implicated in processes such as binding, catalytic activity, transcription and 
translation, and protein secretion are specific to the venom duct.131,159  However, a comparison of second 
level GO annotation of the venom duct transcriptome to the tissue specific transcriptomes from other 
organisms, including non-venomous marine animals, shows a very similar distribution across GO 
categories.160,161 Irrespective of organism or tissue, binding and catalytic activity are always highly 
represented, and speculation that this is specific to the venom duct appears to be misplaced. It is 
important to note that distribution and number of hits among GO categories does not provide information 
about gene expression levels, and as such is limited in providing insight into which GO identified proteins 
may be present in greater abundance for venom production. 
2.2.9. Venom Duct Proteins with Peptide Folding and Processing Function 
Assignment of GO terms provides the means to investigate for the presence of proteins that are known to 
be important to folding and processing of peptide toxins, including peptide disulfide isomerases, cis-trans 
peptidyl prolyl isomerases, heat shock proteins, and proteins that play a role in post translational 
modification, which is of great importance in cone snails.42,43,162,163 Based on limited proteomic data, 
preliminary research suggested that teretoxins lack the heavy post translational modifications found in 
cone snails..45,47  However, preliminary investigation of the C.anilis transcriptome for the presence of post-
translational enzymes similar to those found in the cone snail venom duct yielded a number of candidate 
proteins that may serve a similar function for teretoxins (Table 3). 
Vitamin K dependent γ-glutamyl carboxylase is a post-translational enzyme found in the cone snail 
venom duct that catalyzes the addition of a carboxyl group to specific glutamate residues.164 One 
transcript from our Trinity assembly displays a near perfect match to Conus textile vitamin K-dependent γ-
glutamyl carboxylase, with a BLAST hit of e-value of 0.0 and a bit score of 828. While carboxylation of 
glutamate residues is an established post-translational modification in conotoxins, it should be noted that 
this carboxylase is highly conserved in a wide variety of organisms, including human and drosophila. In 
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mammalian systems it plays an important regulatory role in the blood clotting cascade through the 
carboxylation of blood clotting proteins such as prothrombin.165 
Table 3.  Annotation of posttranslational enzymes and chaperones found in terebrid venom duct 
transcriptome. All proteins listed here were identified from the C. anilis transcripts annotated by gene 
ontology and analyzed for the strength of the BLAST hit.  
Post-translational enzyme Function 
γ-glutamyl carboxylase Gamma-glutamyl carboxylase  adds CO2 to protein-bound glutamic acid 
to form gamma-carboxyglutamic acid 
Peptidyl-α-amidating 
monooxygenase (PAM) 
PAM modifies peptides containing a C-terminal glycine residue through 
cleavage of the glycine followed by amidation of the preceding residue 
Prolyl 4-hydroxylase (PH4) PH4 catalyzes hydroxylation of proline residue to yield (2S,4R)-4-
hydroxyproline (Hyp) 
Glutaminyl-peptide cyclotransferase  Glutaminyl-peptide cyclotransferase converts protein bound glutamine 
residues to cyclic pyroglutamyl residues 
Tyrosyl sulfotransferase Tyrosyl sulfotransferase catalyzes sullfation of tyrosine residues 
Protein disulfide isomerase (PDI) PDI catalyzes the formation and breakage of disulfide bonds between 
cysteine residues within proteins as they fold 
Peptidyl-prolyl cis-trans isomerase 
(PPIase) 
PPIase interconverts the cis and trans isomers of peptide bonds of the 
amino acid proline. 
Heat Shock Proteins (HSP) HSPs are class of functionally related proteins involved in the folding 
and unfolding of other proteins 
Another important enzyme of interest in conotoxin post-translational modification is peptidyl-
glycine α-amidating monooxygenase (PAM), which modifies peptides containing a C-terminal glycine 
residue through cleavage of the glycine followed by amidation of the preceding residue.166 Annotation of 
C. anilis assembly yielded a transcript with strong homology to peptidyl-glycine α-amidating 
monooxygenase A, found in the mollusk Crassotrea gigas, with a BLAST hit of 1 e-79, as well as a 
BLAST hit to the same protein found in Conus bullatus, with an e-value of 4 e-56.  
Hydroxylation of conotoxin mature peptide prolines happens in as many as one out of two 
residues, presumably through the activity of prolyl 4-hydroxylase (PH4), although this specific enzyme 
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has yet to be characterized for any cone snail species.  Preliminary studies have indicated that 
hydroxyprolination may be important for both conopeptide bioactivity and oxidative folding.167 Proline 
hydroxylation is also widely present in humans as the result of PH4 activity, with diverse protein 
substrates, although the best known role is the stabilization of the collagen triple helix.168 Several PH4 
transcripts are present in the proposed terebrid transcriptome assembly, with the most predominant being 
PH4-1, one of the important catalytic subunits of the larger protein.  The PH4-1 transcript identified from 
our assembly has a BLAST hit to Crassotrea gigas PH4-1 with an evalue of 1 e-138. 
Other identified C. anilis protein transcripts with potential post-translational function include, 
glutaminyl-peptide cyclotransferase and tyrosyl sulfotransferase, which are responsible for N-terminal 
cyclization of glutamine to pyroglutamate and sulfation of tyrosine in conotoxins, respectively.42,43 The 
terebrid glutaminyl-peptide cyclotransferase identified had a BLAST hit at evalue 4 e-86 to that of 
Crassotrea gigas, while the terebrid tyrosyl sulfotransferase transcript identified displayed excellent 
homology that of the sea snail Littorina sitkana, with an evalue of 0.0 and bit score of 635. 
In addition to these post-translational enzymes, assembly of terebrid venom duct transcriptome 
also yielded a number of transcripts identified as having protein disulfide isomerase (PDI) activity.  In 
particular, one C. anilis transcript shows a very strong match to a Conus eberneus PDI, with an e-value of 
0.0 and a bit score of 708. Also identified was a transcript with strong homology (e-value 3 e-92) to a 
peptidylprolyl cis-trans isomerase of Conus novaehollandiae, which interestingly was used to facilitate the 
oxidative folding of selected conotoxins in vitro.  A wide variety of heat shock proteins (HSP) are also 
present in the terebrid assembly, including HSPs 22, 40, 60, 70 and 90 and beta-11, with the lowest e-
values found for BLAST hits to other mollusk proteins. The identification of PDI and other folding enzymes 
was expected given the disulfide rich nature of teretoxins. 
While the identification of protein transcripts potentially implicated in post-translation modification 
of teretoxins is of great interest, it remains to be seen whether these modifications will be identified on the 
proteomic level. It is possible the posttranslational enzymes identified are involved in common 
housekeeping processes and not used to modify teretoxins in the venom duct. The recognition 
sequences for posttranslational modification enzymes within the conotoxin precursor structure have yet to 
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be defined, and it is not yet elucidated how, for example, some prolines are selected for hydroxylation 
while others remain unchanged. It has been proposed that glutamate carboxylation in conotoxins 
depends on a specific sequence found in the pro region of the peptide, but this is one of the few cases 
where the process is characterized.  
2.3. Conclusion 
This study applied next generation sequencing and state of the art bioinformatics tools to present 
the first comprehensive look at terebrid venom duct transcriptomes, with a particular focus on 
identification of disulfide rich peptides that can be used as lead compounds for drug development and as 
probes for investigating the structure and function of the nervous system. One hundred and forty nine 
putative teretoxins were identified from C. anilis and T. subulata combined (Table 1). Apart from the 
significant number of potential new teretoxins for investigating cellular processes, the highlights of 
comparative analyses of the assembled terebrid venom duct transcriptome presented include: 1. 
Identification of two novel Cys frameworks, Can_10Cys and Can_12Cys, with conserved pre signal 
sequences, but varying Cys frameworks and intra-Cys amino acid residues, a break from the 
conventional gene superfamily and Cys framework relationship found in conopeptides. 2. Identification of 
PXY motif, which, similar to the ICK motif in conotoxins, may have structural and function implications on 
teretoxin bioactivity, 3. Identification of the first teretoxin gene superfamily, which has sequence homology 
to the H superfamily of conotoxins, 4. The first characterization of enzymes that could be linked to 
posttranslational modification of teretoxins, pending validation by proteomic analyses of terebrid venom 
duct components, and 5. A paucity of Cys framework XI (I superfamily) transcripts, which directly 
contrasts cone snail transcriptomes in which I superfamily conotoxins are largely abundant and are 
among the best characterized as Na+ channel agonists and K+ channel modulators. Analyses of venom 
duct transcriptome implies that while terebrid toxins share organizational features with conotoxins, they 
differ substantially in terms of distribution of Cys frameworks, amino acid composition, and average 
length. The structural differences observed between teretoxins and conotoxins highly suggest teretoxins 
are novel ligands with molecular targets that may be distinct from conotoxins, making terebrid marine 
snails a good resource for identifying novel ligands that manipulate cell signaling in the nervous system. 
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 De novo assembly of the transcriptomes of non-model organisms presents an ongoing challenge 
as a result of potential misassembly or the presence of chimeric transcripts. To ensure a high quality of 
the putative teretoxins identified, two different assembly programs, Trinity and Velvet Oases, were run at 
different parameters, and cross-correlated to validate identified teretoxin transcripts. Digital normalization 
techniques were applied to ease the computational load of assembling in excess of 200 million reads, 
while maintaining assembly coverage and quality. Cross validation, especially in cases where all four 
assemblies provide an exact match, provide a high confidence level in the integrity of these transcripts. At 
the same time, the capture of unique transcripts from different assemblies may represent rarer peptide 
toxins that are identified as a result of different kmer lengths or assembly algorithms.  Subsequent 
validation on the proteomic level would be one potential avenue to establish further confidence in these 
sequences. 
.  
 The expansive number of Illumina reads that formed the basis of terebrid venom duct 
transcriptome assembly allowed for a high depth of coverage that is reflected not only in the number of 
teretoxins captured, but also in the analysis of other components of the transcriptome, as reflected in 
identification of toxin-related genes, of transcripts that can be assigned gene ontology terms to form a 
global portrait of expression, and of transcripts implicated in metabolic pathways via the assignment of 
KEGG terms. The presence of different transcripts coding for enzymes involved in post-translational 
modifications, the same modifications found extensively in conotoxins, raises interesting questions 
regarding previous research suggesting that these modifications are low or absent in terebrid toxins.  All 
posttranslational terebrid transcriptome transcripts can only be validated with certainty on the proteomic 
level, which will be part of the future directions of this research. 
 
Finally, a working bioinformatics pipeline was established for subsequent transcriptome efforts 
that can be easily replicated for other species of terebrids, which will lay the foundation for further 
understanding of how teretoxins compare to those of cone snails and any forthcoming research of other 
conoidean toxins. This research also paves the way for the identification of gene superfamilies with the 
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identification of numerous precursor structures and the identification of conserved signal sequences that 
form the basis of the evolutionary relationships among teretoxins. The large numbers of peptides 
identified in this work as well as the numerous conotoxins being identified from transcriptome work point 
towards the need for the expansion of high throughput methods for both synthesis and bioactivity 
characterization to ensure that newly identified compounds with therapeutic potential can be screened 
rapidly and efficiently.  Progress on this front will surely lead to the identification of compounds with novel 
function, given the vast universe of neuropeptides generated by the naturally occurring combinatorial 
chemistry practiced by species rich venomous organisms.  
2.4. Materials and Methods 
2.4.1. Sample Collection 
The C. anilis specimens used in this study were collected on a 2011 expedition to Inhaca, an island off of 
the coast of Mozambique, where its populous presence suggests successful adaptation to this ecological 
niche. The expedition was a collaboration of the Holford group of The City University of New York and the 
American Museum of Natural History and the Bouchet group of the Muséum national d'Histoire naturelle 
(MNHN) of Paris.  Materials from this expedition was used to obtain venom ducts and salivary glands for 
next generation sequencing projects and to enhance existing phylogenetic reconstructions of the 
Terebridae. A significant diversity of terebrid species were acquired in Inhaca using a combination of 
diving, dredging, vacuum accumulation, and intertidal collection techniques.  As terebrids are nocturnal 
hunters, night dives yielded the most specimens. One particularly successful night dive yielded in excess 
of 100 specimens of C. anilis. Overall, 37 species of terebrids were collected during the 15 days 
expedition to Inhaca. At least eight of the collected Inhaca species are new to phylogenetic tree, including 
T. nitida, G. eddunhami, T. Sandrinae (Fig. 16).  Tissue samples for barcoding and shell vouchers were 
fixed in 80% ethanol and sent to the Paris museum for DNA extraction and sequencing, while venom 
ducts and salivary glands were dissected from specimens and stored in RNAlater and brought back to 
The American Museum of Natural History for transcriptome research. 
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2.4.2. RNA extraction and cDNA preparation 
Total RNA was extracted from eight pooled C. anilis venom ducts with Qiagen RNeasy kit, with DNase 
digestion on column, according to manufacturer’s instructions. 10ng of C. anilis total RNA was used as 
template for Clontech’s SMARTer™ Ultra Low RNA Kit for Illumina Sequencing to perform 1st strand 
cDNA synthesis and 12 cycles of PCR amplification according to manufacturer’s instructions. C. anilis 
cDNA was assessed for quality and concentration with Agilent Bionalyzer, using their high sensitivity DNA 
chip. 
2.4.3. Library preparation and  Sequencing 
The cDNA library was sequenced using Illumina HiSeq™ 2000 technology at the New York University 
Center for Genomics and Systems Biology.  Library construction was performed with the Kapa 
Biosystems Kit for sequencing on two paths of an 8-lane Illumina flow cell.  cDNA was fragmented using 
a Covaris S2 Sonicator (range 300-600 bp) and libraries were amplified 8 cycles.  Library quality was 
analyzed on the Agilent Bioanalyzer using the DNA High Sensitivity Chip. 
 
 
Figure 15. Representative terebrid species collected in Inhaca. 
Top panel: Myurella kilburni, Acus 
dimidiata, Terebra subulata, 
Terebra quoygaimardi(W), 
Cinguloterebra anilis, Perirhoe 
cerithina, Myurella columellaris, 
Myurella nathaliae, Hastula solida, 
Hastula (Impages) hectica, 
Myurella undulata. 
Bottom panel: Striterebrum 
calignosa, Terebra funiculata, 
Hastulopus conspersa, Duplicaira 
mozambiquensis, Terebra 
punctostriata, Terebra succincta, 
Myurella joserosadoi, Terebra 
laevigata, Myurella undulata, 
Duplicaria baileyi,Cinguloterebra 
hoaraui. 
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2.4.4. Read processing and de novo assembly 
Illumina HiSeq generated 288,959,674 paired end reads of 100 bp length with 89.43 % bases having a 
quality score ≥ Q30.  Raw read quality assessment was performed with FastQC to determine the need for 
base trimming and adapter removal (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).  Seqtk 
was used to trim bases from the reads using a default Mott algorithm based on phred score 
(https://github.com/lh3/seqtk) while trimmomatic (http://www.usadellab.org/cms/?page=trimmomatic  was 
used to remove adapter contamination.  Ultimately the quality control process yielded a set of paired end 
reads 66.5 GB in size for a total of 280,143,112 reads. 
The de novo assembly programs Trinity (release date 2014-04-13) and Velvet Oases ((v. 1.2.10 and v. 
0.2.08) were run using default parameters to assemble quality trimmed and normalized reads.   Trinity 
assemblies were run on both Trinity in silico normalized reads, which reduced the number of reads to 
9,204,374, and the full read set prior to normalization.  For the Velvet Oases assemblies, two-pass digital 
normalization reduced the dataset to 23,607,286 paired end reads and 102,935 single end or “orphaned” 
reads.  The Velvet Oases assemblies were constructed over a range of odd-numbered kmer values from 
25 to 55.  
2.4.5. BLAST annotation 
Annotation of the C. anilis venom duct transcriptome was performed by using BLASTx to search for 
assembly contig hits against different databases, including (1) a combined database of conotoxins 
downloaded from Conoserver (www.conoserver.org) and our in house database of teretoxin sequences, 
(2) UniprotKB/Animal Toxin Annotation Program (release 2014_03),  (3) NCBI non-redundant (nr) protein 
database, and (4) UniProtKB/Swiss-Prot (release 2014_03) and UniProtKB/TrEMBL (release 2014_03).    
Assignment of gene ontology terms  was performed  in two parts:  phase one of annotation followed a 
bioinformatics pipeline made freely available online by the Palumbi lab 
(http://sfg.stanford.edu/guide.html)169. After blasting against all three databases, a python script was run 
on significant BLAST hits in combination with a download of Uniprot flatfiles to extract gene names, 
general descriptions, and Gene Ontology (GO) categories, which are then combined in a master 
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annotation metatable.  Running this pipeline on our Trinity DN assembly generated 18, 390 annotated 
contigs with an evalue of 1e-6 or lower. 
The second phase of GO analysis incorporated the use of BLAST2GO (B2G) tools on the SFG results for 
further mapping, annotation and in particular, the use of GoSlim, which employs a reduced set of GO 
terms to provide a broad overview of the gene ontology content without as much specific detail.   
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Chapter 3 
Synthesis of novel teretoxins for 
functional assays 
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3.1. Background: characterizing teretoxin bioactivity  
 
 To date the functional activity of a purified teretoxin has yet to be described.  A recent publication 
characterized crude venom extracts from several terebrid species on rat neuronal nAChRs (α3β2, α3β4, 
α4β2, α4β4, α7) and muscle subtypes (α1β1γδ), and K+ (Kv1.2 and Kv1.3) and Na+ channels (Nav1.2, 
1.3, 1.4, 1.6) expressed in Xenopus oocytes.170 The crude extracts displayed inhibitory activity on 
nAChRs receptors, but had no activity on Na+ or K+ subtypes analyzed. While this result of terebid crude 
venom analyses is promising, it is a very preliminary attempt at characterization and did not successfully 
identify what fraction in the crude venom was responsible for the inhibitory response in nAChR subtypes. 
To successfully identify teretoxins that are bioactive it is imperative to be able to synthesize large 
amounts of peptide toxins for characterization in functional assays. In this dissertation four teretoxins 
were synthesized for biological characterization (Table 1).  
Table 1. Teretoxins synthesized during thesis work. 
Species Peptide 
name 
Peptide sequence 
T. guttata Tg77  SLTELKAGGCPLYCSSQIFCCHGRKCRNVDGRLKCVTEASMLGK 
C. anilis Can6.5  ATKHPECEQYSDCPDNQCCIPSGKTVAFGVSHGVKICVTCL 
C. anilis Can10.1  QLCKCCAKLCHEDRDRTIPCSGGNSQFCEFCKRTKQKIRKDCNTQNEAKALCVGYFTGEC 
C. anilis Can14.1  GGLGRCIHNCMNSRGGLNFIQCKTMCS 
 
 The four teretoxin peptides selected were identified from transcriptomes of Terebra guttata (Tg77) 
and Cinguloterebra anils (Can6.5, Can10.1 & Can14.1). The teretoxins chosen, Tg77, Can6.5, Can10.1, 
and Can14.1, were selected they as have features that are both similar and different from known 
conodiean peptide toxins. Tg77 is a 44 residue peptide identified from cDNA cloning library (Holford, 
unpublished data). Can6.5, a 40 residue peptide with six cysteines, Can10.1, 60 residues in length with 
10 cysteines, and Can14.1, 27 residues with four cysteines, were identified in the next generation 
sequencing and de novo assembly work described in Chapter 2. Tg77 and Can6.5 both have a cysteine 
scaffold, C-C-CC-C-C, corresponding to framework VI/VII of the O gene superfamily. O superfamily 
conotoxins target Na+, K+, and Ca2+ channels, suggesting that Tg77 and Can6.5 may act on similar 
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molecular targets. It should be noted however, that apart from their cysteine scaffold Tg77 and Can6.5 
have no strong sequence homology to known conotoxins and it is therefore hard to predict if they will 
have similar functional activity. Can10.1 has a novel framework not previously identified in conopeptides, 
with cysteine motif C-CC-C-C-C-C-C-C-C. At 60 amino acids, Can10.1 is significantly larger than most 
known conopeptides and is similar in size to scorpion or spider peptide toxins. The unique scaffold of 
Can10.1 suggests it may have functional activity different from previously characterized conotoxins. 
Can.14.1 has framework XIV, C-C-C-C, with strong homology to mature conotoxins AsXIVA from Conus 
Austini, and vil14a from Conus villepini. Conotoxin AsXIVA was shown to elicit scratching and grooming 
activity in mice, and both peptides potentially target K+ channels, although the specific target has yet to be 
fully characterized for either peptide.171 The synthesis and bioactive characterization of teretoxins, Tg77, 
Can6.5, Can10.1, and Can14.1 would significantly enhance existing knowledge of teretoxins and provide 
the first analyses of specific teretoxin bioactivity.  
 Two synthesis strategies were employed to produce teretoxins Tg77, Can6.5, Can10.1, and 
Can14.1 in sufficient quantities for functional characterization: recombinant synthesis and solid phase 
peptide synthesis (SPPS). Due to their large size and cysteine scaffold complexity, Tg77, Can6.5, and 
Can10.1 were synthesized using recombinant expression. Can14.1, which is significantly shorter at 27 
residues, was synthesized using SPPS. Given the structural characteristics of teretoxins, the main focus 
of the research presented here is on designing and executing a reproducible strategy for the recombinant 
expression of neuropeptides of at least 40 residues in length and having six or more cysteines.  The 
synthesis and functional characterization of Tg77, Can6.5, Can10.1, and Can14.1 is described below. 
 
3.1.1. Recombinant expression of teretoxins Tg77, Can6.5, and Can10.1  
  
Teretoxins Tg77, Can6.5, and Can10.1 were all synthesized using recombinant expression, after 
having been identified on the genetic level from the full precursor structure that includes signal sequence, 
pro-region and mature peptide (Fig. 1). Due to the difficulties of collecting sufficient quantities of each 
species, and the limiting amounts of venom found in many specimens, recombinant expression has been 
widely used to produce peptide toxins in amounts that are not generally obtainable from natural sources. 
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For Cys rich peptides from a venom source, the synthesis method chosen must be cost and time 
effective, 
 
Figure 1. Full precursor structure of teretoxins chosen for recombinant expression. Tg77 was 
previously identified from a Terebra guttata cDNA library and two Cinguloterbra anilis peptides, Can.6.5 
and Can.10.1, were identified from next generation sequencing and de novo transcriptome assembly (see 
Chapter 2). 
avoid the common problem of peptide aggregation in the form of inclusion bodies, and facilitate the 
correct formation of disulfide bridges.94,95 A diversity of vectors, hosts, and cloning strategies available for 
recombinant expression in E. coli have been successfully manipulated to optimize venom peptide 
synthesis strategies of several conotoxins, and other peptide toxins from venomous 
organisms.102,103,105,107–109,172–175 Table 2 summarizes several recombinant expression strategies used for 
the synthesis of conotoxins as well as peptide toxins from scorpion, spider and sea anemone.  Some of 
the important considerations include the choice of a fusion tag, where the fusion protein is expressed (i.e. 
periplasmic space or cytosol), and type of cleavage site for release of the mature peptide. Expression as 
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a fusion protein has the advantage of increasing the amount of protein expressed and averting proteolytic 
degradation of the short peptide construct, but in some cases the final enzymatic cleavage step to release 
Table 2. Comparison of recombinant expression strategies for neurotoxins. Main features of 
recombinant expression systems for toxins from cone snails, scorpion, sea anemone and spider. 
Organism Peptide 
features 
N-terminal 
fusion tag 
Purification 
method 
Soluble/ 
insoluble 
E. coli 
host 
Fusion tag 
cleavage 
Reference 
MVIIA (Conus 
magus) 
25 aa 
and 3 
disulfide  
Thioredoxin His tag Soluble  BL21 (DE3) No cleavage Zhan et al., 
2003 
BgK 
(Bunodosoma 
granulifera) 
37 aa 
and 3 
disulfide 
S-tag (C-
terminal) 
S-protein Soluble OrigamiB 
(DE3) 
Tuner 
(DE3) 
No cleavage Braud et 
al., 2004 
Mo1659 (Conus 
monile) 
13 aa 
and no 
cysteine 
Cytochrome-
b5 
His tag Soluble Bl21 (DE3) CnBr Kumar et 
al., 2005 
Conkunitzin-S1 
(Conus striatus) 
60 aa 
and 2 
disulfide 
Chitin binding 
domain 
His tag Insoluble BL21 (DE3) Intein  Bayrhuber 
et al., 2006 
Lt7a (Conus 
litteratus) 
27 aa 
and 3 
disulfide 
Thioredoxin His tag Soluble BL21 (DE3) Factor Xa Pi et al., 
2006 
BTK-2 
(Mesobuthus 
tamulus) 
32 aa 
and 3 
disulfide 
Cytochrome-
b5 
His tag Soluble BL21 (DE3) Tev protease Kumar et 
al., 2009 
Vn2 (Conus 
ventricosus)  
33 aa 
and 3 
disulfide 
Glutathione-S-
transferase 
His tag Soluble BL21 (DE3) No cleavage Spieza et 
al., 2012 
PrIIIE (Conus 
parius) 
22 aa 
and 3 
disulfide 
Small 
ubiquitin-like 
modifier 
(SUMO) 
His tag Soluble Rosetta-
gami B 
(DE3) 
SUMO 
protease 
Hernandez 
et al., 2012 
MrVIB (Conus 
marmoreus)  
31 aa 
and 3 
disulfide 
Pe1B leader 
signal peptide 
His tag Soluble  BL21 (DE3) No His tag 
cleavage 
Gao et al., 
2013 
Huwenotoxin-
IV 
(Ornithoctunus 
huwena) 
35 aa 
and 3 
disulfide 
SUMO His tag Soluble Shuffle T7 
Express 
SUMO 
protease 
Sermadiras 
et al., 2013 
Framework XV 
conotoxins 
(various 
species) 
Varied 
length 
and 4 
disulfide 
Thioredoxin His tag Soluble BL21 (DE3)  Enterokinase Wu et al., 
2014 
 
the mature peptide may prove problematic in terms of specificity of the reaction, as well as obstruction of 
the cleavage site by protein aggregation, resulting in low yield of final product. Interestingly, in several 
different research initiatives that include the use of thioredoxin tag, S-tag and GST-tag, leaving the fusion 
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protein intact has not impeded bioactivity of the toxin.  Ideally, however, steps are taken to successfully 
troubleshoot cleavage problems and produce the desired peptide without the presence of any additional 
residues. Subsequent to vector construction there are numerous choices in to be made in the overall 
research design, even though the overarching steps follow the same progression, proceeding through the 
sequential steps of transformation, induction and expression, protein purification, protease cleavage, and 
verification of the final product with HPLC and mass spectrometry.  
 As a first step, designing an effective recombinant expression protocol benefits from a cloning 
method that has a high rate of efficiency for correctly inserting the gene construct into the plasmid.  
Ligation independent cloning (LIC) has proven to be an adroit method for recombinant plasmid 
construction with a reported 70% efficiency rate.104,176 In contrast to conventional restriction enzyme 
cloning, LIC balances the exonuclease and polymerization activities of T4 DNA polymerase to create 
specific single-stranded 5’ tails on the gene insert complementary to the single-stranded overhangs in the 
target vector. Fragment and vector are combined in the absence of ligases, with circularization of the 
plasmid vector only occurring after annealing of the gene insert through its cohesive ends. LIC was 
applied to the recombinant synthesis of Tg77, Can6.5, and Can10.1. 
3.2. Results and Discussion 
3.2.1. Design and construction of expression system 
Tg77, Can6.5, and Can 10.1 were initially expressed in E. coli strains Nova Blue and Origami B 
(DE3) as pET-32 Xa/LIC plasmid fusion proteins with a thioredoxin tag to aid in solubility and folding, a 
His tag for purification purposes, and an enterokinase site for peptide cleavage (Fig. 2)  
 
Figure 2. Fusion protein organization for soluble protein expression. All teretoxin neuropeptides 
were expressed as fusion protein construct under the control of a pET-32a T7 promoter, with a 
thioredoxin tag to aid in solubility and folding, a 6x histidine tag for purification and and enterokinase site 
for cleavage of the final product. 
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The pET-32 Xa/LIC plasmid, and E. coli strains Nova Blue and Origami B (DE3) (Novagen) are 
important components of an expression system tailored toward expression of cysteine rich peptides. The 
pET-32 Xa/LIC vector was chosen due to the presence of an N-terminal thioredoxin fusion adduct which 
aids in solubility and folding. The vector is pre-linearized with single overhangs in place, which allows for 
the efficient insertion of the gene, and carries an N-terminal 6X Histidine (His) tag for affinity purification. 
For cloning, the NovaBlue host provides high transformation efficiency, good plasmid yield and can also 
be used to produce single stranded plasmid DNA for mutagenesis. The expression host Origami B 
contains a chromosomal copy of the T7 gene for induction of expression, is deficient in ompT proteases 
to prevent protein degradation, and has a trxB/gor double mutation that aids in disulfide bond 
formation.177,178 
The primary amino acid sequence of each teretoxin was back translated into codons optimized 
for expression in E. coli, and a synthetic oligonucleotide was prepared for insertion into the plasmid using 
LIC. In the case of Tg77, primers were designed for PCR amplification of the gene insert to add the 
specific sequence required for the generation of the long single stranded ends that are the hallmark of the 
LIC process.  For Can6.5, and Can 10.1, the PCR reaction was dispensed with by ordering the synthetic 
oligonucleotides as a double stranded “gene blocks” with the additional LIC sequence incorporated at the 
5’ and 3’ end of both strands. In frame insertion of the synthetic oligonucleotide into the pET 32 plasmid 
was verified by colony PCR and Sanger sequencing for all three teretoxin plasmids (Fig. 3).  
 
 
 
 
 
 
Figure 3. Sample colony PCR showing correct gene insertion. In frame insertion of Can6.5 
peptide into pET 32+ LIC plasmid with verification of His Tag, EK site, and peptide sequence 
followed by stop codon.  
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Purified plasmid was then transformed into the expression host, and colonies were screened for positive 
transformants to be used for inoculation of culture and subsequent expression. 
3.2.2. Expression and purification of recombinant fusion proteins 
 
Tg77, Can6.5, and Can 10.1 were transformed expression host E. coli bacteria and grown in 
terrific broth culture. IPTG was added during log phase growth at a concentration of 0.4 mM for induction 
of fusion protein expression.  Induction and growth parameters were varied to find the optimal conditions 
for overexpression of soluble protein, including IPTG concentration, time and temperature of growth, and 
lysis methods.  Expression of Tg77 fusion protein was determined to be the highest with terrific broth 
culture medium, with induction of expression at close to 1.0 OD and 0.4mm IPTG, and overnight growth 
at 25 degrees Celsius.  After overnight induction, lysis by sonication and centrifugation of bacterial 
culture, Tg77 was His tag purified with Nickel-NTA affinity chromatography using a batch purification 
method.  Expression of Tg77 in the Origami host gave an average yield of 20.9 mg per Liter of growth 
medium. Expression and purification of Tg77 were analyzed with 12% SDS-PAGE, confirming 
overexpression of soluble fusion protein at molecular weight of 23.8 kD (Fig. 4).  
 
The Origami strain, while providing a favorable folding environment given the trx and gor 
mutations that help provide a non-reducing environment in the cytosol, does not provide particularly high 
expression levels.  In the interest of generating product more efficiently and in larger amounts, the 
recombinant expression protocol was modified for teretoxins Can6.5, and Can 10.1 by using BL21(DE3) 
Figure 4. SDS-PAGE analysis of expression and purification of Tg77. The lanes of the gel are represented as 
follows: M = protein molecular mass marker. Lane 1 = Tg77 crude lysate.  Lane 2 =Tg77 crude lysate 
supernatant post binding to nickel-NTA resin.  Lane 3 = wash buffer 1 supernatant. Lane 4 = wash buffer 2 
supernatant. Lane 5 = combined imidazole eluted fractions of Tg77 fusion protein. 
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as the expression host, and performing His-tag purification using Fast Protein Liquid Chromatography 
(FPLC).  BL21(DE3) is used routinely for recombinant expression of disulfide rich conotoxins (Table 2).  
The strain BL21(DE3) is known for relatively high expression levels, and the presence of a thioredoxin tag 
in the fusion construct may be sufficient for the objective of disulfide bond formation.  A recent study 
comparing recombinant expression of disulfide rich peptides using a variety of different fusion tag proteins 
in combination with three E. coli strains, including OrigamiB and BL21(DE3), demonstrated that BL21 
more often allowed for the expression of soluble protein.179 With respect to His-tag affinity purification, the 
FPLC method can be readily scaled to larger amounts of protein, and in industrial settings is used to 
generate kilogram amounts of purified protein.   
FPLC chromatograms for His-tag affinity purification of teretoxins Can.6.5 and Can10.1 show 
different elution profiles. The elution profile of Can.6.5 depicts two distinct, sharp peaks at 170 mM and 
250 mM of imidazole, respectively, while Can.10.1 displays a single broad peak at 170 mM (Fig. 5).  
Can6.5 and Can10.1 vary in size, 40 vs. 60 residues, and complexity, which is illustrated by the different 
elution profiles. The two peaks of Can6.5 and the single peak of Can10.1 elute in a comparable range of 
150 to 280 mM imidazole, and 150 to 260 mM imidazole, respectively. It is unclear why Can.6.5 elutes in 
two distinct peaks, whereas Can.10.1 elutes in a single broad peak.  These chromatographic results may 
be explained by variable elution times of monomers versus multimers of the fusion protein, and the 
implications for the final step of protease cleavage. Recently, in the FPLC His-tag purification of  spider 
toxin Huwentoxin-IV, Sermadiras et al. observed that monomers eluted more readily (i.e. earlier) than 
multimers with intermolecular disulfide bridges that are present as aggregates.109  
73 
 
 
Figure 5. Elution profiles FPLC His affinity purification of peptides Can.6.5 and Can.10.1.  A. 
Can.6.5 elution shows two distinct peaks of variable size over an imidazole gradient of 150 to 250 mM 
imidazole.  B. Can.10.1 elutes in a single broad peak over a similar gradient, 150 to 260 mM imidazole. 
A. 
B. 
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Sermadiras, et al. report that optimization of the imidazole elution gradient increased the elution of 
monomers only. Without further analysis varying imidazole concentration to manipulate elution profiles of 
Can.6.5 and Can.10.1 it is difficult to know with certainty if a similar pattern holds, however, Can10.1 has 
10 cysteines in the peptide, which would make the formation of multimers more likely due to misfolding or 
intercysteine bonding.  
To fully characterize the presence of correctly folded monomers as opposed to multimeric 
aggregates, a first step would be to analyze the His-tag purified fusion protein under native PAGE 
conditions, and/or with size exclusion chromatography. These approaches, while not applied to Can6.5 
and Can10.1, would enable the physical separation of monomers from multimers should both be present, 
and allow for the optimization of imidazole based elution of monomeric fusion protein.  
 SDS-PAGE analysis of Can6.5 and Can10.1 fusion protein expression and purification is 
illustrated in Figure 6. Yields in the bacterial host BL21(DE3) are approximately double the amount in 
BL21(DE3) compared to expression of Tg77 in the Origami bacterial host. Induction and expression 
under the same time, temperature and IPTG concentration used for Origami expression led to a yield of 
23 mg of His-tag purified Can6.1 fusion protein, and 20 mg of Can10.1 fusion protein per 500 ml of 
growth medium. 
 
Enterokinase cleavage, HPLC purification and Mass Spectrometry of teretoxins Tg77, Can6.5 and 
Can10.1 
Figure 6. SDS-PAGE analysis of expression and purification of teretoxins Can.6.5 and Can.10.1. The 
gel la es are l beled s follows: A. M = prote n molecular mass ma ker.  Lane 1 = Can.6.5 crude lysate.  
Lane 2 = Can.10.1 crude lysate. B. M = protein molecular mass marker.  Lane 1 = His affinity purified 
Can.6.5. Lane 2 = His affinity purified Can.10.1. The expected protein fusion mass for Can6.5 and Can 10.1 
is 22.2 and 24.7 KDa respectively.  
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Enterokinase cleavage to release Tg77 mature peptide from fusion protein construct was 
optimized by varying the amount of protein substrate relative to enzyme over a range of specified values. 
A ratio of 1 unit rEK enzyme to 50 ug of protein generated the best cleavage results (Fig. 7).   However, 
enterokinase cleavage of the Tg77 mature peptide from the fusion construct produced a low yield of the 
final product even with optimization of rEK usage.  Enterokinase cleavage may produce poor results due 
to lack of specificity and problems with cleavage site accessibility.  Notably, yield of the  
 
Figure 7. Tris-Tricine SDS-PAGE optimization analysis of Tg77 EK cleavage. Varying concentrations 
of rEK were applied to Tg77 fusion protein in 1:10, 1:20, and 1:50 dilutions. The gel lanes are labeled as 
follows: M = protein molecular mass marker. Lanes 1-3 = EK cleavage with rEK to Tg 77 fusion protein 
ration with no protease inhibitor. Lanes 4-6 = EK cleavage with rEK to Tg 77 fusion protein ration with 
protease inhibitor. 
mature peptide after EK cleavage appeared to have an inverse relationship with increasing levels of 
expression of fusion protein after optimization of expression, suggesting that access to the cleavage site 
was being inhibited by problems of protein aggregation. In order to address this obstacle, varying 
concentrations of urea, ranging from 1M to 4M, were added to the cleavage reaction to facilitate 
enterokinase access to the cleavage site. The partially denaturing effects of urea led to a substantial 
improvement in yield of the cleavage reaction, resulting in consistent yields 2.5 mg/ml of Tg77 per L of 
growth media.  
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Fusion cleaved Tg77 teretoxin was purified by semi-preparative Reverse Phase High 
Performance Liquid Chromatography (RP-HPLC) and the mass was confirmed using Liquid 
Chromatography Mass Spectrometry (LC-MS) (Fig. 8).  
 
 
 
Figure 8. Semi-preparative RP-HPLC and LC-MS of Tg77 teretoxin. A. Semi-preparative HPLC 
purification of folded Tg77 with peak elution at 22.45 minutes. B.  LC-MS characterization folded Tg77 
(expected mass = 4756.2 Da, observed mass = 4756.2 Da). The +4, +5, +6, and +7 ion charge states are 
shown.  
 
 LC-MS analysis confirmed the mass of folded Tg77 peptide, and the
of fusion cleaved teretoxin Can6.5 also yielded the 4360.9 Da expected mass of a folded Can.6.5 peptide 
(Fig. 9).  
 
The overall yield of fusion cleaved Can6.5 is low, and the addition of urea as a partial denaturant did not 
have the same remedial effect as seen in Tg77.  As noted previously, increasing expression levels of the 
Can6.5 fusion protein may have an inverse relationship with the efficiency of EK cleavage and it may be 
beneficial to investigate alternative enzymatic cleavage methods such as Factor Xa, which is incorporated 
in the pET-32 Xa/LIC plasmid construct, to improve enzy
Figure 9. Analytical RP-HPLC and LC
analytical scale with peak elution at 14.65 minutes, followed by confirmation with Q
spectrometry of the expected molecular weight of 4360.91423 Da, with
77 
 HPLC and LC
matic cleavage specificity and Can6.5 yield. 
-MS of Can.6.5.  HPLC purification of folded Can.6.5 on an 
-TOF mass 
 an observed mass of 4360.918.
-MS analysis 
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Factor Xa was originally not applied as enzymatic cleavage with this protease would leave additional 
nonnative residues to the mature Can6.5 peptide sequence, which may affect functional characterization 
of the peptide. 
HPLC and LCMS characterization of fusion cleaved Can10.1 did not yield the expected product 
(data not shown.) As illustrated in Fig 6, while it was possible to successfully express fusion Can10.1 
protein, subsequent EK cleavage did not produce the mature Can10.1 peptide. Complications of Can10.1 
EK cleavage may be due to the formation of Can10.1 multimers as suggested by FPLC purification (Fig. 
5).   
3.2.3. Chemical synthesis of Can.14.1 teretoxin 
Cinguloterebra anilis teretoxin Can.14.1 was identified from de novo transcriptome assembly and 
is homologous to Conus austini conotoxin AsXIVA (Fig 10). Chemical synthesis of Can.14.1 teretoxin was 
accomplished using base labile Fmoc solid phase peptide synthesis (SPPS). 
  
Can14.1 synthesis was initiated by attaching the first Can.14.1 carboxy-terminal amino acid 
serine (Ser) to a Wang-chloride polystyrene resin, which resulted in a load volume of 0.4 mm/g (Fig. 11).   
Figure 10. Can.14.1 teretoxin alignment to Conus austini AsXIVA peptide. Shown is the full 
precursor structure of Can.14.1 showing signal peptide and precursor structure aligned to AsXIVA 
mature peptide.  Blue boxes indicate sites of amino acid difference between the mature peptides 
AsXIVA and Can.14.1.  
  
 
 
After the initial loading of Ser, chain elongation was carried out on a CEM Liberty Microwave Peptide 
Synthesizer for the production of linear Can14.1 peptide. The line
from the Wang resin using a Reagent K cocktail composed of scavengers to prevent unwanted reaction 
of the sidechain protecting groups being removed (Fig. 12). 
 
 
 
Figure 12. Teretoxin Can.14.1 cleavage from Wang
cleaved from the resin by treatment of Reagent K, which contains trifluoroacetic acid (TFA), ethanedithiol 
(EDT), Triisopropylsilane (TIS), and water. The resin was incubated in Reagent K for 4 hours at RT and
peptide was recovered by ether precipitation at 4°C .
Figure 11. SPPS attachment of Can14.1 First Amino Acid (Serine) to Wang resin.
protected Serine amino acid (Fmoc-
temperature in preparation for Can14.1 peptide chain elongation on CEM automated microwave 
synthesizer. The remaining residues of Can14.1 are added in stepwis
Chapter 1 until the mature Can14.1 peptide is synthesized.
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-Cl resin. The assembled Can.14.1 peptide chain is 
  
 Fmoc 
Ser(tBU)-OH) was reacted with Wang-chloride resin at room 
e manner as described in 
 
 the 
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Despite the numerous Cys residues present, folding of conoidean peptides is readily achieved through 
thiol assisted air oxidation.86 Linear Can14.1 was oxidatively folded in solution with reduced and oxidized 
forms of glutathione (GSH/GSS), which is used to initiate disulfide bond formation of the four cysteine 
residues in the peptide. Can14.1 folding reaction was monitored via Ultra High Performance Liquid 
Chromatography (UHPLC) over 0 to 24 hours at room temperature. Folding of the peptide proceeded 
rapidly, with the folded species present within one half hour. The transition from linear Can14.1 to folded 
Can14.1 is illustrated in Figure 13. As peptides fold they become more hydrophilic as hydrophobic 
residues are buried in the folded conformation, resulting in a shift to the left in UHPLC traces.  Folded 
Can14.1 elutes as a single peak at 1.7 minutes in more polar gradient, compared to linear Can14.1 which 
elutes at 2.4 minutes, in a less polar gradient (Fig. 13).  
 
  
 
 
Figure 13. RP-uHPLC elution time profiles for oxidative folding of linear Can.10.1. Overlay of 
oxidative folding reaction of Can.14.1 at 0 minutes folding (2.4 min elution), at 15 minutes folding 
(1.8 min elution) and at 30 minutes folding (1.7 min elution).  Based on these results subsequent 
folding reactions were carried out at 37 deg C and for a duration of 30 minutes. 
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Folded Can14.1 was purified by semi-preparative RP-HPLC and the mass was confirmed by LC-MS (Fig. 
14). 
 
3.3. Functional characterization of teretoxins in polychaete worm assay 
 Teretoxins Tg77, Can 6.5, Can 10.1, and Can14.1 are novel venom peptides, and as such their 
molecular targets are unknown. As described in Chapter 1, conoidean peptides are active on a plethora 
of ion channels and receptors in the nervous system.15 Identifying the specific molecular target of a novel 
teretoxin is similar to finding a needle in a hay stack as there are a myriad of potential molecular targets.  
As a preliminary screen for teretoxin bioactivity, a global phenotypic assay using Nereis virens, N. virens, 
polychaete worms was applied. Polychaete worms are the natural prey of terebrid marine snails and 
Figure 14. Semi-preparative RP-HPLC and LC-MS characterization of folded Can14.1. A. 
Semipreparative RP HPLC purification of folded Can.14.1 on a semi-preparative scale with peak 
elution at 20.19 minutes. B. LC-MS spectra confirms the mass of folded Can14.1 mass (expected 
mass= 2895.2 Da, observed mass = 2895.2 Da). 
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assays of this type have been previously performed to analyze conoidean toxin effect in N. virens and the 
nematode C. elegans.47,180  
 N. virens is a typical free moving or “errant polychaete” (L. errare, to wander) that lives in shallow 
marine waters and is widely dispersed in the North Atlantic region.181  They average 20 to 40 cm in 
length, with highly segmented bodies and parapodia that function in both locomotion and gas exchange.  
The nervous system consists of a brain, which is found in the head region and is connected to the ventral 
nerve cord and the sub-pharyngeal ganglia, while the circulatory system is composed of two main blood 
vessels, with smaller vessels to supply the parapodia and the gut (Fig. 15).182 Injections of teretoxin and 
control peptides are targeted to the double and ventral nerve cord.  
N. virens can engage in either crawling or swimming. In swimming they throw their bodies into sinusoidal 
S-shaped curves generated by the contraction and relaxation of the longitudinal muscles in the 
segmented body divisions. In contrast to most marine organisms, the swimming forward motion results 
from “reversed” posterior to anterior waves that nonetheless propel the worm forward when combined 
with the turbulence created by the parapodia (Fig 16).183 Observation of N. virens swimming pattern upon 
injection of teretoxin and control peptides provides a phenotypic response that can be related to teretoxin 
bioactivity.  
Figure 15. Generalized scheme of polychaete anatomy.  Body cross section shows location of 
double and ventral nerve cords.  Injection of teretoxin and control peptides is targeted to this area 
(Image adapted from http://lanwebs.lander.edu/faculty/rsfox/invertebrates/nereis.html). 
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 Purified Tg77 was assayed five times in N. virens to deteremine its bioactivity in terms of 
phenotypic disruption of polychaete worm movement (Table 3). Worms were injected 12 to 20 ul of 21uM 
Tg77, alongside positive and negative controls that included injection with 1uM omega agatoxin, injection 
with normal saline solution, respectively, and observation of a worm that was not injected. Test worms are 
placed in 4 identical saltwater baths at room temperature. Directly after injection, the worm response is 
videotaped over an approximate 3-4 hour period. After one hour, a cold stimulus is applied by placing 
worms in a 4 deg C water bath to determine recovery time. 
Injection of Tg77 results in an initial partial or complete paralysis of N. virens, followed by 
uncoordinated swimming movement, twisting, and rigid extension of parapodia. This effect is observable 
within 15 to 30 seconds post injection. After a short period of uncoordinated movement, the worm 
assumes a state of complete immobility. Each assay was video recorded to monitor the worms over a 3-4 
hour period and was reviewed both by visual observation and digitally tracked with the computer software 
WormLab.114 A video still of the worm assay is provided in Figure 18. 
Figure 16. Polychaete N. virens swimming motion. During swimming contraction of longitudinal 
muscles in inner body segments and relaxation of out body segments throw their bodies 
into sinusoidal S-shaped curves. The parapodia paddle backward exerting thrust, during their power 
strokes. The main thrust during swimming, however, comes from the force exerted by the undulating 
body on the water (Image adapted from http://cronodon.com/BioTech/Polychaete.html). 
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Table 3. Testing of Tg77 in N. virens for phenotypic response 
 
Polychaete body 
mass (g) Injections 
Assay 1 
4.16 20uL 21uM TG77 
1.778 No injection 
2.919 20uL normal saline 
4.878 20uL 1uM w-agatoxin 
Assay 2 
4.16 12uL 21uM TG77 
5.42 No injection 
5.962 12uL normal saline 
4.878 20uL 1uM w-agatoxin 
Assay 3 
1.785 20uL 21uM TG77 
1.778 No injection 
2.919 12uL normal saline 
2.737 12uL 1uM w-agatoxin 
Assay 4 
4.965 12uL 21uM TG77 
5.42 No injection 
5.962 12uL normal saline 
4.878 12uL 1uM w-agatoxin 
Assay 5 
5.083 12uL 21uM TG77 
1.778 No injection 
2.919 12uL normal saline 
2.737 12uL 1uM w-agatoxin 
 
A preliminary analysis using WormLab to analyze the moving average speed of worms injected 
Tg77, as well as positive and negative controls, is presented in Figure 17.  The positive and negative 
numbers along the Y-axis represent the worm movement in opposite directions. Although N. virens has a 
generally sinusoidal movement, it is not a particularly good swimmer leading to irregular movement and 
alternation with crawling.  As a result, WormLab was not always tracking the motion of the worm 
effectively, as its tracking algorithm is based on a geometric analysis that looks for more regular 
sinusoidal swimming motion found in C. elegans. When N. virens motion deviates from a predictable 
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wave pattern, WormLab cannot track the worm and has to be manually manipulated to recapture the 
tracking.  Thus, while this graph represents a first step towards achieving a true quantitative assessment 
of changes to worm motion upon injection of teretoxin, it is not yet able to capture with fidelity the overall 
phenotypic response from the peptide. Efforts are ongoing to rectify the tracking algorithm so that a 
comprehensive picture of worm movement over a period of time can be obtained. Visual assessment of 
the teretoxin effect is currently the best measure of behavioral change in looking for signs of 
uncoordinated movement or paralysis, which is clearly observable in the case of Tg77 as seen in the 
video footage within a few minutes of injection.  
 
Figure 17.  Preliminary results of polychaete moving average speed using WormLab.  Video software 
footage over a 40 minute period was used to analyze moving average speed of N. virens after injection with 
Tg77 and controls.  Video is taped at 30 frames/sec and moving average speed is analyzed in microns/sec 
with positive and negative values reflecting opposite bending angles. WormLab tracking coverage may be 
dropped temporarily if the worm movement deviates too much from regular sinusoidal movement, resulting 
of varying coverage of individual worms. 
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Figure 18. Video still image from polychaete worm assay.  After injection with Tg77, omega-agatoxin, 
normal saline, or no injection, worms were videotaped for a 3-4 hour period to characterize phenotypic 
changes in behavior. 
Based on repeated phenotypic response of paralysis observed in N. virens upon injection of 
Tg77, Tg77 was submitted to collaborator Dr. Ibanez-Talon for further characterization to determine the 
specific molecular target using electrophysiology. Thus far, it has not been possible to identify a specific 
target for Tg77.  Additional functional assays are being pursued to continue this effort. Similar to Tg77, 
Can6.5 and Can14.1 will be provided to collaborators for identification of their molecular target, based on 
the results of initial phenotypic assays.  
3.4. Conclusion 
One of the main goals of this dissertation project has been to design and execute a reproducible 
strategy for the synthesis of cysteine rich teretoxins in good yield for downstream functional assays. To 
this end, four novel teretoxins, Tg77, Can6.5, Can10.1, and Can14.1 were synthesized using recombinant 
expression and chemical synthesis methods.  
The recombinant synthesis approach employed LIC as a high efficiency technique for reliable 
insertion of the gene of interest into the plasmid, avoiding the common problems inherent to a restriction 
enzyme approach.  To optimize the yield of teretoxins being expressed, several modifications in bacterial 
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expression strains and enzymatic cleavage conditions were conducted. Specifically, while expression of 
Tg77 in OrigamiB plasmid and RP-HPLC was effective, expression of  Can10.1 and Can 14.1 teretoxins 
BL21(DE3) followed by FPLC His-tag affinity purification doubled the expression of Can 6.5 and Can 10.1 
fusion proteins compared to Tg77.  Yield of enterokinase cleavage was greatly enhanced for Tg77 by the 
addition of 2-3M urea to the cleavage reaction, but did not have the same positive effect for cleavage of 
Can.6.5 and Can.10.1 mature peptides. Cleavage has been partially successful for Can.6.5 and an 
accurate mass for the folded confirmation has been obtained. Enzymatic cleavage and synthesis of 
Can.10.1 was inconclusive, which is not entirely surprising considering the high number of cysteines and 
the increased potential for aggregation and misfolding. 
There are a number of potential avenues to pursue in order to increase the yield of the cleavage 
reaction.  A first step would be to evaluate more closely problems of aggregation and misfolding even in 
species that are isolated from the soluble expression fraction, as indicated by the presence of monomeric 
versus multimeric species.  Very interesting questions are raised as to when the formation of inclusion 
bodies results from aggregation during the expression process itself, and when multimeric or misfolded 
species may still be present as soluble forms but as a result prove resistant to successful protease 
cleavage.  Given the weak conditions for protein folding in E. coli, even in the presence of engineered 
strains, it has been proposed that folding may actually occur ex-vivo in lysis and purification steps where 
the presence of a favorable pH (typically close to 8.0) and high concentrations of molecular oxygen 
provide favorable folding conditions.179  If this is in fact the case, these steps could be optimized for 
correct folding by the addition of oxido shuffling reagents to the buffers, or possibly ab initio denaturation 
and refolding of the peptide in the fusion form prior to cleavage.  On a different front, if lack of specificity is 
leading to low cleavage, then altering proteases, such as using FactorXa or Tev may prove more 
effective.  Although it would be worth exploring both alternatives, it appears more likely that aggregation is 
the biggest hurdle, given the greater difficulty of cleavage in the ten Cys Can.10.1 
In this body of research the chemical method of SPPS has also been explored as a means to 
synthesize teretoxin peptides and was successfully applied to the synthesis of Can.14.1, a 27 residue 
peptide with four cysteines.  SPPS has proven to be very effective the production of this short peptide, 
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with at least 8 milligrams of folded peptide prepared for bioactivity assays.  However, it still remains the 
case that SPPS becomes more difficult and cost prohibitive with increased peptide length, which makes 
recombinant expression an attractive alternative in many cases88. 
Functional characterization of synthesized teretoxins was performed using a phenotypic 
polychaete N. virens worm assay. Characterization of Tg77 was performed chiefly by visual observation 
of the videotaped footage. Compared to saline injected worms, Tg77 injection caused partial or complete 
paralysis. Injection of Tg77 generated uncoordinated movement and paralysis in repeated trials, similar to 
the effect of the positive control omega-agatoxin IVA, which acts as a P-type calcium channel antagonist. 
These preliminary findings are promising, but subsequent attempts to identify a specific molecular target 
for Tg77 were inconclusive.  
In summary, with the successful synthesis of Tg77, Can6.5, Can10.1 and Can14.1, significant 
strides have been made towards the recombinant and chemical synthesis of teretoxin during this 
research period. Characterization of the molecular targets of these teretoxins is an ongoing effort in the 
Holford laboratory.     
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3.5. Materials and methods 
3.5.1. Recombinant plasmid construction 
Synthetic oligonucleotide gene inserts for all three peptides were obtained by back translation of 
respective peptide amino acid sequence and the addition of an N terminal enterokinase cleavage site, 
according to standard E. coli codon usage.  PCR primers were designed to add the requisite LIC 
oligonucleotide sequence to the 5’ and 3’ ends of the gene specific insert for the subsequent generation 
of long sticky ends and directional cloning: 
5’ATATTATATTATTTAGATGACGACGACAAGAGCCTGACCGAACTGAAAGCGGGCGGCGGCT
CGCCGTATTGCAGCAGCCAGATTTTTTGCTGCCATGGCCGCAAATGCCGCAACGTGGATGGC
CGCCTGAAATGCGTGACCGAAGCGAGCATGCTGGGCAAATAAATATTATTA-3’ 
5’-GGTATTGAGGGTCGC-3’  Forward LIC extension 
GATGACGACGACAAG    Enterokinase site 
5’-AGAGGAGAGTTAGAGCCA-3’   Reverse LIC extension 
 
Tg77 Forward Primer 
5’-GGTATTGAGGGTCGCATATTATATTATTTA -3’ 
Tg77 Reverse Primer 
5’-AGAGGAGAGTTAGAGCCATAATAATATTTA-3’ 
The commercially available pET-32 Xa/LIC Vector Kit (EMD Millipore) supplied the plasmid vector 
as ready-to-use linear double-stranded DNA with single stranded overhangs for annealing to target DNA. 
PCR amplified oligonucleotide was purified with SpinPrep Gel DNA Kit (Novagen), treated with T4 DNA 
Polymerase in the presence of dGTP to generate vector-compatible overhangs, and annealed to the pre-
linearized vector according to the manufacturer’s protocol.  The plasmid construct was initially 
transformed into the E. Coli NovaBlue competent cells and screened for successful transformation with 
ampicillin/carbenicillin and kanamycin resistance markers.  Verification of target gene insertion in the LIC 
vector in the correct reading frame was verified by colony PCR, according to manufacturer’s protocol. 
The two C. anilis peptides, Can.6.5 and Can.10.1 were handled in the same manner as the above, with 
one exception.  Rather than PCR amplification of the synthetic oligonucleotide, double stranded DNA 
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gene blocks (IDT) were designed with LIC extensions pre-incorporated and ready for immediate 
treatment to generate single stranded ends for annealing to vector.  Treatment to generate single 
stranded overhangs followed the same protocol of treatment with T4 DNA polymerase in the presence of 
dGTP, and correct insertion of target gene was also verified with colony PCR.  Oligonucleotide synthesis 
of double stranded gene blocks were based on the following oligonucleotide sequences: 
Can6.5 
5’GGTATTGAGGGTCGCGATGACGACGACAAGGCGACCAAACATCCGGAATGCGAACAGT
ATAGCGATTGCCCGGATAACCAGTGCTGCATTCCGAGCGGCAAAACCGTGGCGTTTGGCGTG
AGCCATGGCGTGAAAATTTGCGTGACCTGCCTGTAATGGCTCTAACTCTCCTCT 3’ 
Can10.1 
5’GGTATTGAGGGTCGCGATGACGACGACAAGCAGCTGTGCAAATGCTGCGCGAAACTGTG
CCATGAAGATCGCGATCGCACCATTCCGTGCAGCGGCGGCAACAGCCAGTTTTGCGAATTTT
GCAAACGCACCAAACAGAAAATTCGCAAAGATTGCAACACCCAGAACGAAGCGAAAGCGC
TGTGCGTGGGCTATTTTACCGGCGAATGCTAATGGCTCTAACTCTCCTCT 3’ 
3.5.2. Induction and Expression 
The Trx-His-neuropeptide construct was plasmid purified with QIAprep Spin Miniprep Kit (Qiagen) and 
transformed into the E. coli Origami strain. A single colony from a fresh plate was used to inoculate a 
primary culture, which was grown overnight at 37°C and 250 RPM to saturation. The following morning, a 
larger culture was inoculated using the overnight pre-culture and incubated at 37°C and 250 RPM until 
optical density (OD) measured at 600nm reached a value of 0.8 -1.0. IPTG was then added to a final 
concentration of 0.4mM to induce expression of the Trx-His-peptide fusion protein. The culture was grown 
overnight at 25°C and 250 RPM for overexpression of  soluble protein. The bacteria were harvested by 
centrifugation (8,000g, 10 minutes, 4°C) and the pe llet was stored at -20°C until his tag purification. 
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3.5.3. Protein extraction and His Tag Affinity Purification 
The bacterial pellet was resuspended in sodium phosphate buffer (100mM Na-PO4, pH 8.0, 300 mM 
NaCl, 10% glycerol) and lysed by sonication with Fisher Scientific Model 120 Sonic Dismembrator at 
three rounds of 70% power for 30s and three rounds at 90% power for 30s for soluble protein extraction.  
Cleared lysate was generated by centrifugation at 13,000g for 45 min and filtered (0.2 micron). 
Two methods were pursued for 6x His tag purification.  Tg77 was treated with a batch purification method 
using Nickel-NTA resin (Qiagen) pre-equilibrated with lysis buffer (100 mM Na-PO4, 300mM NaCl, 10% 
glycerol, 1 mg/ml lysozyme, pH 8.0).   Binding of cleared fusion protein lysate to nickel-NTA resin was 
followed by treatment with two wash buffers [wash buffer 1 (50 mM Na-PO4 pH 7.7, 300 mM NaCl, 10mM 
imidazole, 10% glycerol)and wash buffer 2 (50mM NaPO4 pH 7.7, 2M NaCl, 10mm imidazole, 10% 
glycerol)].   His tagged protein was eluted sequentially with two elution buffers [elution buffer 1 (50mM 
Na-PO4 pH 7.7, 300mM NaCl, 20mM imidazole) and elution buffer 2 (50 mM Na-PO4 pH 7.7, 300 mM 
NaCl, 500 mM imidazole, 10% glycerol)]. 
C. anilis fusion proteins were purified with FPLC using a 5ml HisTrap HP column (GE Healthcare) 
charged with NiSO4 on an ÄKTA Purifier system (GE Healthcare). Two buffers (Buffer A: 50mM Tris/HCl 
pH 8.5, 10 mM imidazole, 500mM NaCl and Buffer B: 50mM Tris/HCl pH 8.5, 1M Imidazole, 500M NaCl) 
were used to generate the imidazole gradient. The flow rate was maintained at 5ml/min. The column was 
equilibrated for 5 column volumes (CV) with buffer A. The lysate was then loaded (typically 150ml), 
followed by at 15 column volume wash step.  Elution was performed using an imidazole gradient from 0 to 
50% Buffer B (500 mM imidazole) followed by an increase to 100% Buffer (I M imidazole to clear the 
column.  Elution fractions of 2ml each were collected and analyzed by SDS PAGE for the presence of His 
purified fusion protein.  
3.5.4. Enterokinase cleavage 
Enterokinase protease (EMD Millipore and Syd Labs) was used to cleave peptide from the fusion protein 
at the recognition site DDDK according to manufacturer’s protocol.  Optimization of reaction conditions 
was conducted at enzyme-substrate ratios of 1:10, 1:20 AND 1:50, and over a time range of 5 hours to 
overnight.   After optimization, the reaction was run at enzyme to substrate ratio of 1:50 and overnight in 
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duration to ensure full cleavage.   Cleavage yield was enhanced by adding urea to the enterokinase 
reaction, from 1-4 M concentrations, in order to generate partially denaturing reaction conditions. 
3.5.5. HPLC purification and Mass Spectrometry 
Cleaved Tg77 was purified by RP-HPLC using an X-Bridge C18 semi-preparative column (10 x150 mm, 5 
um particle size, Waters Corporation, Milford, MA, USA) pre-equilibrated with 95% buffer A (0.1% TFA)). 
Elution was carried out at 5 mL/min over a linear gradient of buffer B (80% acetonitrile 0.1% TFA) from 
5% to 75% in 30 min.  HPLC buffer composition remained the same all through the work.  
ESI-mass spectra were recorded on an Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS. 
Samples were delivered to the mass spectrometer through chromatographic separation on the Agilent 
HPLC 1290 and monoisotopic average masses of peptides were calculated from sequence information 
using the UCSF ProteinProspector MS-Product tool (http://prospector.ucsf.edu/prospector/mshome.htm). 
Observed mass was calculated from m/z charged states using MassHunter Bioconfirm Qual B.05 
software and compared to expected mass allowing for the reduction in mass of the folded peptide (1 Da 
per oxidized cysteine in formation of disulfide bridges). 
3.5.6. Solid Phase Peptide Synthesis 
Method for attachment of the first residue to resin: Wang chloride resin (1.0 g, 1.1mmol/g) was swelled in 
10 ml DMF at room temperature for 30 minutes. Fmoc-Ser(tBU)-OH (3.3 mmol, 3 equivalents), Potassium 
Iodide [KI (0.33 mmol, 0.3 equivalents)] and N,N-Diisopropylethylamine [DIEA (3.3 mmol, 3 equivalents)] 
were added to the resin and the suspension was shaken for 16 to 24 hours. The loaded resin was 
successively filtered and washed with Dichloromethane (DCM), Dimehtylformamide (DMF) and methanol, 
and dried under vacuum. The final substitution rate was determined photometrically from the amount of 
Fmoc chromophore released upon treatment of the resin with piperidine/DMF, by taking the UV 
absorbance at 301 nm and using a standard formula to calculate loading.  Unreacted resin was then 
endcapped with 11 equivalents of DIEA and 10 equivalents of acetic anhydride to prevent unwanted side 
reactions during peptide elongation. 
Peptide elongation and cleavage of final product: TA1 peptide was synthesized by microwave assisted 
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Fmoc SPPS on a CEM Liberty synthesizer using standard side chain protection. Standard Fmoc cysteine 
side chain protecting group Trityl (Fmoc-Cys (Trt)-OH) was used for all cysteine residues.  Cleavage was 
performed by treatment of peptidyl resin with Reagent K 92.5% Trifluoroacetic acid (TFA), 2.5% 
Triisopropylsilane (TIS), 2.5% 1,2 Ethanedithiol (EDT)) and 2.5% water] for four hours. 
Oxidative Folding of Tv1: A one-step thiol-assisted oxidation was used to prepare folded Ta1 peptide. The 
linear peptide (20 mM) was incubated in 0.1 M Tris–Hydrochloride (Tris_H0.1 M Sodium Chloride (NaCl), 
100 mM Ethylenediaminetetraacetic acid (EDTA), 1 mM Glutathione (GSH), 1 mM Glutathione Disulfide 
(GSSG), pH 7.5 at room temperature and 37 deg C. The folding reaction was terminated by acidification 
with 8% formic acid at 15 min, 30 min, 1, 2, 3, 4, and 24 h and the folding yield monitored using UHPLC. 
UHPLC injections were run over a 0 to 75% gradient of buffer B (80% acetonitrile in water, 0.1% TFA) in 
buffer A (water, 0.1% TFA) gradient at a flow rate of 0.4 ml/ min for 3.5 minutes. A preparative scale 
folding reaction was then conducted at an optimized time of 30 min and 37 deg C, and the folded peptide 
was purified using an X-Bridge semipreparative column over gradient B from 30 to 55% acetonitrile. 
3.5.7. Polychaete Worm Assay 
N. virens were obtained either from the commercial vendor Marine Biolabs or from local bait shop and 
then maintained in a saltwater and sand environment at 4° C.  Lyophilized neuropeptides were dissolved  
into normal saline solution at the appropriate concentration and volume to prepare for injection. Injections 
were performed with A Becton Dickinson ½ cc U-100 insulin syringe and targeted to the anterior ventral 
nerve between the 5th and 7th body segments, at a depth of ~0.5 mm.  Prior to injection the worms are 
placed in 4 identical salt water baths at room temperature and allowed to acclimate.  Once injected with 
either peptide or saline solution, the worm is place immediately back in the salt water bath and 
videotaped over an approximate 4-6 hour period.   After one hour, a cold stimulus is applied by placing 
worms in a 4 deg C water bath for 60 seconds, after which they are returned to RT water baths to assess 
recovery time.   
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Conclusion and future directions 
 
Conclusion and future directions 
 
Venom from marine organisms is a gift from nature to biomedical research. The diversity of 
compounds, the precise selectivity for molecular targets, and rapid efficiency when dispersed cannot be 
replicated without considerable effort. The small fraction of conoidean neuropeptides that have been 
characterized to date suggests investigation of conoidean venom is still in its early stages, yet the power 
of peptides found in snail venom to deliver therapeutic agents for the treatment of pain, a hugely 
underserved market for drug development, has already been established.8,27,184  Beyond neurological 
disorders, conoidean peptides also hold promise as anti-microbials, anti-cancer agents, and 
cardioprotective compounds, with other possibilities restricted only by the rate at which they can be 
identified, synthesized, and functionally characterized33,34.  
This dissertation project significantly characterized the venom composition of an understudied 
member of the conoidean superfamily, the Terebridae, and provided a reproducible research strategy for 
further discovery and characterization of teretoxins in the Holford lab. A venomics approach which 
combines a phylogenetic framework with next generation sequencing and bioinformatics analysis was 
applied to unravel the complexities of the terebrid venom duct transcriptome, The results of this work 
include: comprehensive analysis of the venom duct transcriptome of two terebrid species, the 
identification of the first teretoxin gene superfamily, two novel conoidean peptide cysteine frameworks, a 
reproducible recombinant synthesis strategy for obtaining large quantities of teretoxins for functional 
assays. Four novel teretoxins, Tg77, Can6.1, Can10.1, and Can14.1, were successfully synthesized and 
preliminary attempts were made to characterize their bioactivity. It is important to note, that 
characterization of teretoxin bioactivity and identification of their molecular target is not a trivial pursuit 
given the multiplicity of ion channels and receptors on which they are active. The astonishing diversity of 
methods for manipulating the nervous system displayed by predatory marine snails makes the search for 
a specific target a complicated endeavor.  This research has shed light on the path towards identifying 
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therapeutic peptides for manipulating cellular communication in the nervous system. Summarized below 
are the specific details that generated the results achieved in this dissertation.  
As demonstrated by this research, the first step in the discovery process is identification of the 
multitude of peptide toxins expressed by an individual species of venomous marine snail, in this case, the 
terebrid. Classic Sanger sequencing techniques have been almost completely replaced by next 
generation sequencing, which may be used to elucidate entire transcriptomes and genomes with greater 
speed and at a fraction of the cost compared to older technologies.62  The research performed here has 
employed the latest next generation sequencing technology and bioinformatics tools to reconstruct the 
first terebrid transcriptome, in order to begin the work of characterizing as many teretoxins as possible 
from an individual species and lay the groundwork for synthesis and testing. The analysis pipeline 
developed for the de novo assembly and analysis of the C. anilis venom duct transcriptome was then 
performed for the preliminary characterization of the T. subulata.  Taken together this work has led to the 
identification of ~150 novel teretoxins, laying the groundwork for subsequent peptide synthesis and 
functional characterization.  In addition, the analysis of the full teretoxin precursor structures identified 
through transcriptome analysis will enable the identification of gene superfamilies, which is ultimately 
important to understanding pharmacological activity. This research has led to the characterization of the 
first teretoxin gene superfamily, supported by an analysis of teretoxins from three different species that 
present the same signal sequence in association with a canonical six Cys framework. 
Bioinformatics analyses were also conducted to obtain a portrait of the venom duct transcriptome 
in its broad outlines, through annotation of the transcriptome of possible venom-related genes, 
housekeeping genes as categorized by gene ontology function, and enzyme classification for a brief look 
at enzymatic pathways. Of particular interest was the annotation of proteins with a post-translational 
modifying function. Heavy post-translational modification is a salient feature of conotoxins, but is less well 
understood in teretoxins. Future work on the proteomic level, using advanced techniques in mass 
spectrometry, will be important to validate not only the teretoxin transcripts identified here, but also the 
degree of post-translational modifications on the teretoxins themselves.  
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The world of next generation sequencing and bioinformatics has evolved at a dramatic rate over 
the last few decades, and will undoubtedly continue to provide the research community with new tools 
and technologies.   De novo assembly in the absence of a reference genome remains can still be 
improved, making it vital to stay abreast of the latest sequencing technologies and downstream analysis 
tools to obtain the most accurate and comprehensive reconstruction of genetic information, In particular, 
sequencing technology is a rapidly changing field, with competing technologies such as Illumina, 
IonTorrent, and Oxford Nanopore, as well as others, vying for dominance to produce ever longer and 
more accurate reads. At the same time, without bioinformatics software tools that can provide reliable 
assemblies and downstream analysis, having vast amounts of “big data” is not remotely useful.  
Bioinformatics programs tend to co-evolve with the sequencing technologies available, and in the future 
are likely to undergo as substantial alterations as the sequencing technology itself. 
Proceeding transcriptome assembly and analysis, identification of teretoxins leads to the 
important step of synthesis, either by recombinant expression or SPPS. As a naturally occurring resource, 
teretoxins are only available in minute quantities, making synthesis a necessary task to obtain the 
milligram or greater quantities needed for functional assays.  In this body of research, four teretoxins, 
Tg77, Can6.1, Can10.1, and Can14.1, have been synthesized, three by recombinant expression and one 
by SPPS.  Devising a reproducible strategy for recombinant expression in E. coli has been a particular 
focus, since the length of teretoxins makes them more suitable for this approach than chemical synthesis.  
Here, Tg77 teretoxin from T. guttata was expressed successfully in good yield, with the application of 
mass spectrometry confirming the presence of the folded species.  Using largely the same approach, two 
peptides identified from the C. anilis transcriptome work described in Chapter 2 were recombinantly 
expressed with modifications of immobilized metal affinity purification and choice of E. coli host employed 
to improve yield.  Finally, a shorter, 27 residue peptide also identified the C. anilis transcriptome work was 
synthesized using SPPS and oxidatively folded to produce milligram quantities of peptide.  
The recombinant expression of disulfide rich proteins in an E. coli host has varying degrees of 
success depending on the number of cysteines present and the amino acid composition.100  Efforts will be 
ongoing to tackle problems of protein aggregation that interfere with the final step of proteolytic cleavage 
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that reduces yield of the final product.  There are a wealth of options for optimizing the production of 
disulfide rich proteins in a bacterial host, with the emerging availability of newly engineered strains that 
enhance disulfide formation, as well as alternative fusion tags and proteolytic cleavage sites providing 
new avenues for exploration. High throughput techniques for experimenting with different constructs are 
becoming more readily available and facilitate the optimization of conditions in micro format prior to scale 
up.  It is also worth noting the potential of expressing disulfide rich proteins in a eukaryotic host, which 
has been performed successfully in P. pastoris, as this approach has many of the advantages of E. coli in 
terms of low cost and well developed protocols, while providing a more favorable folding environment.110  
Synthesis of peptides in quantity has set the stage for functional assays, which were performed 
primarily through the use of a worm assay, using the polychaete N. virens.  Injection of Tg77 into 
polychaete worms in micromolar quantities produced uncoordinated swimming and paralysis in repeated 
trials, similar to the effect observed upon injection of the positive control ω-agatoxin IVA.  Subsequent 
electrophysiological testing in the lab of Dr, Ines Ibanez-Tallon did not produce any specific information 
about molecular target, and other tests will be ongoing to see if the Tg77 mechanism of action can be 
pinpointed.  Electrophysiology is a time and labor intensive endeavor, with no single assay providing a 
catch all for potential neuropeptide target, especially where phenotypic evidence does not suggest a 
particular line of attack.   
As such, both synthesis, and to a greater degree, testing in functional assays, is the bottleneck 
impeding a more rapid characterization of the functional aspects of neuropeptides produced by venomous 
organisms.  Identifying sheer numbers of potential toxins of interest is scaling up rapidly with the advent 
of transcriptomics and genomics, which may be especially powerful when integrated with state of the art 
proteomics.49  Certainly there are many advances in peptide synthesis and electrophysiology techniques, 
but realizing these on a genuinely high throughput level is still in need of advancement.   Putting together 
the whole package promises to further capitalize on the therapeutic promise of conoidean neuropeptides. 
In summary, this dissertation assisted in unraveling the complexities of the terebrid venom duct 
transcriptome. As such, it successfully identified and characterized specific venom components for further 
development in the Holford lab.  
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Supplementary Table 1. Trinity and Velvet Oases assembly statistics for C. anilis 
 
 
 
 
 
 
 
  
 Number of 
reads 
Assembly size 
(bp) 
# contigs > 200 
bp 
Mean contig size 
(bp) 
Median contig size 
(bp) 
N50 
(bp) 
Trinity digital 
normalization 
 
9,204,374 
 
71,641,414 
 
105,768 441 677 964 
Trinity all reads  
280,143,112 172,425,581 290,811 420 592 757 
Velvet Oases Kmer 27  
23,607,286 122,663,519 187,143 452 655 863 
Velvet Oases Kmer 33  
23,607,286 132,650,654 181,356 509 731 994 
Velvet Oases kmer 39  
23,607,286 126,084,601 147,925 550 852 1,271 
Velvet Oases kmer 45  
23,607,286 118,783,256 139,914 551 848 1,271 
Velvet Oases kmer 51 23,607,286 
104,256,362 127,804 532 815 1,213 
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